,Gene_set,Term,Overlap,P-value,Adjusted P-value,Old P-value,Old Adjusted P-value,Odds Ratio,Combined Score,Genes
0,KEGG_2021_Human,Neuroactive ligand-receptor interaction,111/341,3.5014285044851074e-15,1.0854428363903833e-12,0,0,2.668372489278443,88.81839364639887,CHRM3;PRSS1;NPFFR1;VIPR2;HTR4;RXFP2;CYSLTR1;HTR7;ADORA1;PRSS2;GHSR;CHRNB4;LHCGR;NPY1R;GABRG3;GABRG2;MTNR1A;AGTR1;AGTR2;PTGFR;CALCA;CHRNA4;CHRNA7;CHRNA6;CHRNA9;LPAR3;GPR83;NTS;KNG1;MCHR2;C3;C5;MC2R;CALCR;HRH3;NPBWR1;PENK;TAC4;CGA;HCRT;DRD2;GRIA4;HTR1E;HTR1F;GH2;PYY;GNRH2;RLN3;GABRB2;GABRB1;HTR2B;HTR2C;ADM;ADRA1D;OXT;TRH;ADRA1B;GRM1;LTB4R;GABRR3;MC4R;GHR;GABRR1;UCN3;UCN2;PRLHR;INSL5;AVPR1B;EDN3;GPR35;GLP2R;PTH2R;SSTR1;F2;SSTR2;ADRA2B;ADRA2A;SSTR4;GIP;CCKBR;CRH;OPRD1;PTGER2;P2RY6;GLRA3;NPW;P2RY4;NPY;P2RY1;KISS1R;PRLH;GABRE;GPR156;S1PR5;GABRQ;GABBR2;GABRA1;SLURP2;GABRA5;GABRA4;GCGR;GABRA3;SCTR;GPR50;AGT;SLURP1;GRIN1;POMC;SST;GHRH;F2RL2
1,KEGG_2021_Human,Staphylococcus aureus infection,39/95,2.2294064358126624e-09,3.4555799755096266e-07,0,0,3.799974514619341,75.7013080371191,CFI;KRT24;KRT23;KRT20;ICAM1;C2;C4B;C3;KRT33B;C4A;KRT33A;C5;HLA-DMA;KRT25;HLA-DPA1;MBL2;HLA-DRB5;FGG;DEFA5;KRT35;KRT13;KRT34;KRT32;KRT10;KRT31;KRT9;KRT19;KRT18;KRT17;KRT38;KRT16;KRT37;KRT15;KRT36;KRT14;DSG1;DEFB4A;CFB;HLA-DQB1
2,KEGG_2021_Human,Maturity onset diabetes of the young,17/26,1.4048106924917634e-08,1.451637715574822e-06,0,0,10.262050456253355,185.54585806060777,ONECUT1;HNF4G;PDX1;HNF1B;PAX6;BHLHA15;HNF1A;MAFA;GCK;NEUROD1;RFX6;HNF4A;NKX6-1;MNX1;FOXA3;FOXA2;NEUROG3
3,KEGG_2021_Human,Bile secretion,36/90,2.0670832622235733e-08,1.601989528223269e-06,0,0,3.63447828904731,64.31042939652234,UGT1A10;ABCB4;SLC22A1;SLC2A1;AQP4;ADCY2;ADCY8;SLC4A4;SLC4A5;AQP1;UGT1A4;UGT2A1;UGT1A9;UGT1A8;UGT1A7;SULT2A1;ABCC3;ABCG8;ABCG5;UGT2B11;UGT1A1;SLC10A2;UGT2B15;NR1H4;SCTR;UGT2B17;ATP1B3;ATP1B1;BAAT;SLC51B;NR0B2;SLC9A3;SLCO1A2;UGT2B4;SLC22A7;CFTR
4,KEGG_2021_Human,Complement and coagulation cascades,33/85,1.835688422631495e-07,1.1381268220315268e-05,0,0,3.4567945812685212,53.61722101689536,CPB2;SERPINA1;CFI;C4BPA;C4BPB;C8B;TFPI;C8A;KNG1;C2;C4B;C3;C4A;THBD;C5;C6;C9;CD55;MBL2;FGB;FGA;SERPINB2;SERPIND1;FGG;F11;F2;F5;F7;PROC;CFHR4;KLKB1;CFB;F2RL2
5,KEGG_2021_Human,Metabolism of xenobiotics by cytochrome P450,30/76,4.289874361646274e-07,2.2164350868505748e-05,0,0,3.5502559199055064,52.05327788320551,UGT1A10;ADH1B;ADH7;ADH4;ALDH3B2;HPGDS;AKR7A3;ALDH3B1;UGT1A4;UGT2A1;UGT1A9;UGT1A8;UGT1A7;SULT2A1;GSTM4;GSTM3;GSTM2;UGT2B11;GSTM1;UGT1A1;UGT2B15;UGT2B17;AKR7L;ALDH3A1;GSTA5;CYP2S1;GSTA2;GSTA1;UGT2B4;GSTM5
6,KEGG_2021_Human,Nicotine addiction,19/40,2.107404557638909e-06,9.332791612400884e-05,0,0,4.915105197734911,64.24068757353287,GABRQ;GABRB2;GABRA1;GABRB1;CHRNA4;GABRA5;CHRNA7;GABRA4;CHRNA6;GABRA3;CACNA1B;GABRG3;GABRG2;GRIN1;GABRR3;GABRR1;SLC17A7;GABRE;GRIA4
7,KEGG_2021_Human,Ascorbate and aldarate metabolism,15/30,1.1438557670530266e-05,0.0004432441097330478,0,0,5.4274219504345025,61.75603278113822,UGT1A10;KL;MIOX;UGT2B11;UGT1A1;UGT2B15;UGT2B17;ALDH2;RGN;UGT1A4;UGT2B4;UGT2A1;UGT1A9;UGT1A8;UGT1A7
8,KEGG_2021_Human,Retinol metabolism,25/68,1.681417762845185e-05,0.0005791550072022304,0,0,3.1604102995396897,34.74330100337918,UGT1A10;ADH1B;HSD17B6;ADH7;SDR16C5;ADH4;RDH12;RDH16;AOX1;UGT1A4;UGT2A1;BCO1;UGT1A9;UGT1A8;UGT1A7;CYP3A7-CYP3A51P;UGT2B11;UGT1A1;UGT2B15;UGT2B17;CYP26A1;CYP2W1;ALDH1A2;CYP2S1;UGT2B4
9,KEGG_2021_Human,Taste transduction,29/86,2.51213325971937e-05,0.000773496805841776,0,0,2.7669100005104905,29.306538441316675,KCNK5;CHRM3;PDE1C;TAS2R46;ADCY8;GRM1;CALHM1;P2RY4;GNAT3;P2RY1;TAS1R2;TAS1R1;TAS2R3;SCN3A;TAS2R4;TAS2R50;GABBR2;GABRA1;TAS2R30;HTR1E;GABRA5;HTR1F;GABRA4;GABRA3;HTR3C;TAS2R13;HTR3A;HTR3B;SCNN1B
10,KEGG_2021_Human,Drug metabolism,34/108,2.7446660852450116e-05,0.000773496805841776,0,0,2.5002450637165663,26.260739074731216,CDA;UGT1A10;ADH1B;DPYS;GMPS;ADH7;ADH4;ALDH3B2;HPGDS;ALDH3B1;AOX1;UGT1A4;UGT2A1;UGT1A9;UGT1A8;UGT1A7;GSTM4;GSTM3;GSTM2;UGT2B11;GSTM1;UGT1A1;UGT2B15;UGT2B17;FMO1;FMO3;FMO5;ALDH3A1;UCK2;GSTA5;GSTA2;GSTA1;UGT2B4;GSTM5
11,KEGG_2021_Human,Cell adhesion molecules,41/148,0.00011956627914032544,0.0030887955444584,0,0,2.08577443298844,18.837963180875988,CNTNAP2;NLGN1;NRXN1;LRRC4;NRXN2;VTCN1;CLDN2;CLDN1;ICAM1;CLDN20;HLA-DMA;CDH3;CLDN24;CLDN23;NRCAM;HLA-DPA1;NLGN4Y;HLA-DRB5;CADM1;CD8B2;SELE;CLDN6;IGSF11;CLDN11;OCLN;CLDN3;CD40LG;CLDN9;CLDN8;CNTN1;CLDN19;ITGA8;CNTN2;CLDN18;CLDN17;ITGA6;CDH15;CLDN16;HLA-DQB1;ITGA9;NECTIN1
12,KEGG_2021_Human,Protein digestion and absorption,31/103,0.0001546182676130829,0.0036870509969273,0,0,2.3409630108918367,20.5408999562474,COL17A1;KCNK5;PRSS1;CPB2;SLC1A1;COL11A2;SLC3A1;COL19A1;DPP4;KCNN4;PRSS2;CPA2;COL26A1;MME;COL25A1;COL22A1;KCNJ13;ATP1B3;ATP1B1;SLC9A3;SLC7A8;MEP1A;SLC7A9;COL4A4;KCNQ1;COL7A1;COL4A3;COL4A6;COL9A1;COL4A5;COL9A3
13,KEGG_2021_Human,Steroid hormone biosynthesis,21/61,0.0002288344073346148,0.0050670475909807,0,0,2.8506772009029344,23.895835639610684,UGT1A10;CYP3A7-CYP3A51P;UGT2B11;UGT1A1;SRD5A2;UGT2B15;HSD17B3;AKR1C3;UGT2B17;HSD17B6;CYP17A1;STS;SULT1E1;CYP21A2;HSD17B1;UGT2B4;UGT1A4;UGT2A1;UGT1A9;UGT1A8;UGT1A7
14,KEGG_2021_Human,Estrogen signaling pathway,37/137,0.0004305426890182597,0.0088978822397107,0,0,2.0122722852512154,15.596044061048872,SHC3;CALML5;KRT24;KRT23;CALML3;ADCY2;KRT20;ADCY8;GRM1;KRT33B;KRT33A;CREB3L3;CREB3L1;KRT25;HRAS;GABBR2;KCNJ9;KRT35;KRT13;KRT34;KRT32;KRT10;KRT31;ESR1;KRT9;POMC;KRT19;KRT18;KRT17;KRT38;KRT16;KRT37;KRT15;KRT36;KRT14;TFF1;FKBP4
15,KEGG_2021_Human,Cytokine-cytokine receptor interaction,67/295,0.0007971229655198554,0.0154442574569471,0,0,1.60155913515376,11.426326221225064,CNTFR;CXCL6;IL1RN;IL20;CSF2;CSF3R;IL25;AMHR2;EPO;IL24;CXCL17;CXCL1;IL1RAP;CXCL13;EDA2R;GHR;IL36A;IL36B;CCR9;IL11;IL1R2;TNFRSF18;IL19;TGFBR2;EDAR;IL1A;IFNK;XCL1;IL6ST;CCL14;CX3CR1;CCL13;IL20RB;CSF2RA;ACVR1C;THPO;IL36RN;CCL17;CCL15;IL12RB2;TNFSF18;GDF10;NGFR;IL31;TSLP;TNFSF15;CD70;GDF15;IL37;TNFSF13;TNFRSF10C;IL36G;PPBP;GDF5;BMP7;BMP6;IL2;EPOR;IL1F10;BMP5;GH2;CD40LG;ACKR3;INHA;IL17C;CCL26;CRLF2
16,KEGG_2021_Human,Pentose and glucuronate interconversions,13/34,0.0011595620682181,0.0211449553616251,0,0,3.3564765887056014,22.688818003063865,UGT1A10;KL;UGT2B11;UGT1A1;UGT2B15;UGT2B17;AKR1B10;UGT1A4;UGT2B4;UGT2A1;UGT1A9;UGT1A8;UGT1A7
17,KEGG_2021_Human,Salivary secretion,26/93,0.0016928952813294,0.0288559673464294,0,0,2.107129083265842,13.446254492681147,CHRM3;CALML5;ADRA1D;CALML3;ADCY2;AQP5;ADRA1B;BEST2;ADCY8;STATH;HTN1;RYR3;CST5;HTN3;DMBT1;MUC7;PRKG2;NOS1;KCNN4;AMY1A;AMY1B;ATP1B3;ATP1B1;LYZ;MUC5B;TRPV6
18,KEGG_2021_Human,Arachidonic acid metabolism,19/61,0.0017685915470392,0.0288559673464294,0,0,2.4544910455319737,15.555513197431203,PLA2G2F;GPX2;PLA2G12B;PLA2G1B;PLA2G2C;PLA2G4B;CYP4F2;ALOX15;CYP4F3;AKR1C3;PLA2G4A;PLA2G3;PLAAT3;ALOX12;ALOX12B;ALOX15B;HPGDS;PLA2G10;LTA4H
19,KEGG_2021_Human,Hematopoietic cell lineage,27/99,0.0020708036353081,0.0320974563472761,0,0,2.0362681744749596,12.58376777107174,GYPA;CSF2;CSF3R;TFRC;EPO;CD1E;CD1C;CD1B;CSF2RA;CD1A;HLA-DMA;THPO;ANPEP;CD55;HLA-DPA1;IL11;HLA-DRB5;MME;IL1R2;ITGA1;CD8B2;DNTT;EPOR;GP9;IL1A;ITGA6;HLA-DQB1
20,KEGG_2021_Human,ECM-receptor interaction,24/88,0.0035579373659588,0.0525219325451066,0,0,2.035264686894771,11.475991144227155,TNXB;ITGB4;LAMA1;ITGA1;LAMB4;LAMC2;THBS4;DSPP;COMP;GP9;FRAS1;IBSP;SV2B;COL4A4;ITGA10;COL4A3;CHAD;COL4A6;ITGA8;COL9A1;COL4A5;ITGA6;COL9A3;ITGA9
21,KEGG_2021_Human,Morphine addiction,24/91,0.0056398343986064,0.0794703937985447,0,0,1.9437865546380428,10.064733520594592,GABRQ;GABRB2;GABBR2;GABRA1;GABRB1;PDE1C;GABRA5;KCNJ9;PDE4D;GABRA4;PDE4C;GABRA3;CACNA1B;ARRB1;ADCY2;ADCY8;GABRG3;GNG11;GABRG2;GABRR3;GNGT1;GABRR1;ADORA1;GABRE
22,KEGG_2021_Human,Basal cell carcinoma,18/63,0.0064171653257571,0.0864922283036836,0,0,2.169201030927835,10.951816171012284,WNT10B;WNT2B;FZD4;WNT3A;HHIP;FZD7;WNT7B;WNT5A;LEF1;FZD6;FZD10;GLI1;KIF7;GLI2;WNT6;WNT11;SMO;DVL3
23,KEGG_2021_Human,Linoleic acid metabolism,10/29,0.0097695435107936,0.1192559228058159,0,0,2.851271817074821,13.197070369044829,PLA2G2F;PLA2G12B;PLA2G1B;PLA2G2C;PLA2G4B;ALOX15;PLA2G10;PLA2G3;PLA2G4A;PLAAT3
24,KEGG_2021_Human,cAMP signaling pathway,47/216,0.0100732725689569,0.1192559228058159,0,0,1.5111810266031651,6.948213367334561,VIPR2;CALML5;NPR1;HHIP;PTGER2;CALML3;ADCY2;CACNA1D;OXT;HTR4;GLI1;ADCY8;PLD1;HCAR2;HCAR3;MC2R;HCAR1;CREB3L3;CREB3L1;NPY;ADORA1;CNGA3;CNGA4;CGA;DRD2;GRIA4;VAV3;GABBR2;GHSR;LHCGR;EDN3;HTR1E;HTR1F;PDE4D;PDE4C;NPY1R;ATP1B3;SSTR1;ATP1B1;SSTR2;GRIN1;GIP;POMC;ADCY10;SST;PPP1R1B;CFTR
25,KEGG_2021_Human,alpha-Linolenic acid metabolism,9/25,0.0102970385607582,0.1192559228058159,0,0,3.046859942177963,13.942123190285384,PLA2G2F;PLA2G12B;PLA2G1B;PLA2G2C;PLA2G4B;PLA2G10;PLA2G3;PLA2G4A;PLAAT3
26,KEGG_2021_Human,Chemical carcinogenesis,51/239,0.0111063716783895,0.1192559228058159,0,0,1.47431012145188,6.634743941160868,UGT1A10;ARRB1;FGF3;FGF4;HPGDS;FGF8;CREB3L3;FGF9;CREB3L1;RPS6KA2;KPNA7;UGT2A1;HRAS;SULT2A1;CYP3A7-CYP3A51P;CHRNB4;UGT2B11;UGT1A1;UGT2B15;UGT2B17;CDC25A;BIRC5;UGT2B4;AIPL1;CHRNA4;CHRNA7;CACNA1B;CHRNA9;ADCY2;CACNA1D;ADCY8;EIF4EBP1;FGF20;UGT1A4;UGT1A9;UGT1A8;UGT1A7;SULT1A2;GSTM4;GSTM3;GSTM2;GSTM1;JAG1;KLF4;ESR1;GSTA5;KLF5;GSTA2;GSTA1;FGF18;GSTM5
27,KEGG_2021_Human,Gastric acid secretion,20/76,0.0111602073247151,0.1192559228058159,0,0,1.936768904854011,8.706552377227565,CHRM3;CALML5;KCNJ16;CALML3;ATP1B3;ADCY2;ATP1B1;SSTR2;ADCY8;MYLK3;ATP4B;ATP4A;SLC9A4;CCKBR;SST;KCNQ1;GAST;KCNJ1;KCNK2;CFTR
28,KEGG_2021_Human,Porphyrin and chlorophyll metabolism,13/43,0.0116897990878291,0.1192559228058159,0,0,2.348279189449984,10.447584969526234,UGT1A10;UGT2B11;UGT1A1;UGT2B15;UGT2B17;CP;HEPHL1;UGT1A4;UGT2B4;UGT2A1;UGT1A9;UGT1A8;UGT1A7
29,KEGG_2021_Human,Calcium signaling pathway,51/240,0.0120175058515373,0.1192559228058159,0,0,1.4664216712409484,6.483623390669332,RET;CHRM3;CALML5;HTR2B;HTR2C;CALML3;ADRA1D;HTR4;ADRA1B;RYR3;FGF3;MYLK3;GRM1;FGF4;CYSLTR1;HTR7;FGF8;FGF9;KDR;NOS1;LHCGR;AVPR1B;SPHK1;TNNC1;TNNC2;TRDN;CCKBR;ITPKA;AGTR1;PPIF;MET;PTGFR;PDE1C;CHRNA7;CACNA1B;ADCY2;CACNA1D;MST1R;ADCY8;GNA14;ERBB4;FGF20;NTRK2;NOS2;VEGFD;GRIN1;GDNF;FGF19;FGF18;FGFR3;FGFR2
30,KEGG_2021_Human,Signaling pathways regulating pluripotency of stem cells,33/143,0.012021578104213,0.1192559228058159,0,0,1.6284881838782777,7.199631054066202,WNT2B;DLX5;HOXD1;ONECUT1;FZD10;SOX2;WNT6;ACVR1C;WNT11;DVL3;HOXA1;OTX1;HRAS;LEFTY2;WNT10B;LEFTY1;FZD4;WNT3A;FZD7;WNT7B;ESX1;WNT5A;ESRRB;FZD6;PAX6;KLF4;DUSP9;MAPK12;LHX5;IL6ST;FGFR3;NEUROG1;FGFR2
31,KEGG_2021_Human,Amoebiasis,25/102,0.0126949853309416,0.1192559228058159,0,0,1.7613400483920345,7.690976251932124,SERPINB10;CSF2;SERPINB13;LAMA1;HSPB1;CD1E;CXCL1;LAMC2;CD1C;C8B;CD1B;C8A;CD1A;GNA14;C9;SERPINB3;SERPINB4;NOS2;ARG1;IL1R2;LAMB4;COL4A4;COL4A3;COL4A6;COL4A5
32,KEGG_2021_Human,Pancreatic secretion,25/102,0.0126949853309416,0.1192559228058159,0,0,1.7613400483920345,7.690976251932124,CHRM3;PRSS1;CPB2;PLA2G1B;PLA2G3;ADCY2;ADCY8;SLC4A4;CLCA2;CLCA1;PRSS2;CLCA4;PLA2G2F;CPA2;PLA2G12B;AMY1A;PLA2G2C;AMY1B;SCTR;ATP1B3;CEL;ATP1B1;KCNQ1;PLA2G10;CFTR
33,KEGG_2021_Human,Histidine metabolism,8/22,0.0143381372574585,0.1288268902232606,0,0,3.0945958344802276,13.136040510271744,ALDH3A1;ALDH3B2;AOC1;HAL;ALDH2;ALDH3B1;CARNS1;HNMT
34,KEGG_2021_Human,Glycerophospholipid metabolism,24/98,0.0145449714768197,0.1288268902232606,0,0,1.7591820354893306,7.4422371015980495,PLA2G2F;ACHE;PCYT1B;PCYT1A;PLA2G12B;PNPLA7;PLA2G1B;PLA2G2C;DGKA;PLA2G4B;LPCAT1;PLA2G3;PLA2G4A;PLAAT3;PLD1;CRLS1;ETNPPL;PTDSS1;ETNK2;GPD1;PLA2G10;GPD1L;LPIN2;PLA1A
35,KEGG_2021_Human,Ether lipid metabolism,14/49,0.0152094691365932,0.1309704286762194,0,0,2.1676962676962677,9.073623405924083,PLA2G2F;GAL3ST1;PLA2G12B;PLA2G1B;PLA2G2C;PLA2G4B;LPCAT1;PLA2G4A;PLA2G3;PLAAT3;PEDS1;PLD1;PLA2G10;ENPP6
36,KEGG_2021_Human,GABAergic synapse,22/89,0.016871545863703,0.139409714926724,0,0,1.7806547905633126,7.268858557941831,GABRQ;GABRB2;GABBR2;GABRA1;GABRB1;GABRA5;GABRA4;GABRA3;CACNA1B;GAD2;SLC6A11;ADCY2;CACNA1D;ADCY8;GABRG3;GNG11;GABRG2;GABRR3;GNGT1;GABRR1;HAP1;GABRE
37,KEGG_2021_Human,PPAR signaling pathway,19/74,0.0170889327974693,0.139409714926724,0,0,1.8728913368294613,7.62140209679382,HMGCS1;MMP1;SCD5;APOA2;UCP1;AQP7;ACSL5;APOA1;LPL;CYP8B1;FABP3;FABP4;ACOX2;FABP5;FABP7;ME1;SLC27A6;HMGCS2;PLIN5
38,KEGG_2021_Human,Arrhythmogenic right ventricular cardiomyopathy,19/77,0.0255775561658158,0.1991130051170689,0,0,1.7757009345794392,6.509790697366525,DSP;ACTN3;JUP;ITGB4;LAMA1;CACNA2D1;ITGA1;LEF1;CACNA2D3;CACNA2D2;CACNA1D;CACNG6;GJA1;ITGA10;ITGA8;ITGA6;SGCG;DSC2;ITGA9
39,KEGG_2021_Human,Glycolysis / Gluconeogenesis,17/67,0.0259674846304714,0.1991130051170689,0,0,1.8426795491143315,6.7274574040824495,ADH1B;ADH7;ENO3;G6PC1;HK2;GCK;ALDH3A1;ADH4;ALDH3B2;ALDH2;HKDC1;ALDH3B1;PGM2;ALDOC;ALDOB;FBP1;GAPDH
40,KEGG_2021_Human,Systemic lupus erythematosus,30/135,0.0263343006767736,0.1991130051170689,0,0,1.5498983552023655,5.636798950775539,MACROH2A2;C8B;C8A;C2;C4B;H2AC11;C3;C4A;H2AC12;C5;H3C15;HLA-DMA;C6;C9;H3C1;H4C2;H4C1;H2BW1;H2BW2;ELANE;H3C7;HLA-DPA1;H2BC9;H3C8;H2AC8;HLA-DRB5;H2BC3;CD40LG;H2BC11;HLA-DQB1
41,KEGG_2021_Human,Fat digestion and absorption,12/43,0.0282893932480305,0.2088026644497495,0,0,2.09691940670055,7.476080375336594,PLA2G2F;ABCG8;ABCG5;PLA2G12B;PLA2G1B;NPC1L1;PLA2G2C;PLA2G10;PLA2G3;APOA1;CEL;APOB
42,KEGG_2021_Human,"Neomycin, kanamycin and gentamicin biosynthesis",3/5,0.0296687977342075,0.2138913325024265,0,0,8.116062840654056,28.549544472645135,HKDC1;GCK;HK2
43,KEGG_2021_Human,Nitrogen metabolism,6/17,0.0379238028187463,0.2612528638624746,0,0,2.952561559108414,9.661302020951435,CA12;CA1;CA3;CPS1;CA4;CA9
44,KEGG_2021_Human,Phenylalanine metabolism,6/17,0.0379238028187463,0.2612528638624746,0,0,2.952561559108414,9.661302020951435,ALDH3A1;ALDH3B2;TAT;ALDH3B1;PAH;MIF
45,KEGG_2021_Human,Galactose metabolism,9/31,0.042578194643666,0.2869400073812276,0,0,2.2151096574482376,6.99180096256269,MGAM2;AKR1B10;HKDC1;PGM2;LALBA;LCT;G6PC1;HK2;GCK
46,KEGG_2021_Human,Starch and sucrose metabolism,10/36,0.0445018926216002,0.2874080565145014,0,0,2.0827565750444927,6.482004082373182,MGAM2;AMY1A;TREH;AMY1B;HKDC1;PGM2;ENPP3;G6PC1;HK2;GCK
47,KEGG_2021_Human,Tyrosine metabolism,10/36,0.0445018926216002,0.2874080565145014,0,0,2.0827565750444927,6.482004082373182,ADH4;ALDH3B2;ALDH3A1;HGD;ADH1B;TAT;ALDH3B1;AOX1;MIF;ADH7
48,KEGG_2021_Human,Glutathione metabolism,14/57,0.0522671505630546,0.3306697280519785,0,0,1.7635658914728682,5.204965801192111,GSTM4;GSTM3;GPX2;GSTM2;GSTM1;HPGDS;GCLC;GSTA5;ANPEP;GSTA2;GSTA1;CHAC2;GCLM;GSTM5
49,KEGG_2021_Human,Carbohydrate digestion and absorption,12/47,0.0533979723066622,0.3310674283013061,0,0,1.8568305006890216,5.440480882739019,MGAM2;GNAT3;AMY1A;AMY1B;HKDC1;CACNA1D;TAS1R2;ATP1B3;ATP1B1;LCT;G6PC1;HK2
50,KEGG_2021_Human,Renin-angiotensin system,7/23,0.0556338393995414,0.334682280782436,0,0,2.368258426966292,6.841812486972307,MME;ANPEP;AGTR1;REN;KLK2;AGTR2;AGT
51,KEGG_2021_Human,Cushing syndrome,32/155,0.0561402535506021,0.334682280782436,0,0,1.410687504933302,4.062642037205175,WNT2B;LEF1;KCNA4;CACNA1D;ADCY2;FZD10;ADCY8;CYP17A1;WNT6;MC2R;RASD1;WNT11;CREB3L3;CREB3L1;DVL3;WNT10B;FZD4;WNT3A;FZD7;WNT7B;WNT5A;FZD6;AGT;NR5A1;POMC;CDK6;STAR;CYP21A2;AGTR1;CRH;AIPL1;KCNK2
52,KEGG_2021_Human,Renin secretion,16/69,0.0633179461219877,0.3703502509021926,0,0,1.6353011213840527,4.5127548668978905,CALML5;EDN3;PDE1C;NPR1;PTGER2;CALML3;CACNA1D;AGT;AQP1;ADORA1;AGTR1;CLCA2;PRKG2;CLCA1;REN;CLCA4
53,KEGG_2021_Human,Serotonergic synapse,24/113,0.067962181824441,0.3901532660291983,0,0,1.4613850182430128,3.92937770452969,TPH2;GABRB2;GABRB1;HTR1E;HTR1F;KCNJ9;PLA2G4B;ALOX15;CACNA1B;HTR2B;HTR3C;HTR2C;PLA2G4A;ALOX12;CACNA1D;HTR3A;ALOX12B;HTR3B;HTR4;ALOX15B;GNG11;GNGT1;HTR7;HRAS
54,KEGG_2021_Human,Cortisol synthesis and secretion,15/65,0.0731106419374127,0.4120781636472356,0,0,1.624847119407789,4.25024477900927,KCNA4;ADCY2;CACNA1D;ADCY8;AGT;CYP17A1;NR5A1;POMC;MC2R;CREB3L3;STAR;CYP21A2;CREB3L1;AGTR1;KCNK2
55,KEGG_2021_Human,Regulation of lipolysis in adipocytes,13/55,0.0778101709960261,0.4307348751565735,0,0,1.676147589946239,4.280014583834942,NPR1;IRS4;NPY1R;AQP7;PLAAT3;ADCY2;ADCY8;FABP4;NPY;ADORA1;PRKG2;CGA;MGLL
56,KEGG_2021_Human,Cholesterol metabolism,12/50,0.0799556176422711,0.4348463415632291,0,0,1.7099339989846,4.319778180631744,ABCG8;ABCG5;STAR;NPC2;APOH;APOA2;PCSK9;APOA1;LPL;LRP2;LPA;APOB
57,KEGG_2021_Human,ABC transporters,11/45,0.0818448722882531,0.4374467311958359,0,0,1.7516970143891697,4.384374350982967,ABCC3;ABCG8;ABCC1;ABCG5;ABCB4;ABCA3;ABCC5;ABCC6;ABCA8;ABCA13;CFTR
58,KEGG_2021_Human,beta-Alanine metabolism,8/30,0.0841671981118754,0.4422344307573118,0,0,1.96835406083961,4.871577892233072,ALDH3B2;ALDH3A1;ALDH2;DPYS;ALDH3B1;CARNS1;GADL1;GAD2
59,KEGG_2021_Human,Viral protein interaction with cytokine and cytokine receptor,21/100,0.0917965439096191,0.467581221975416,0,0,1.4400377175186443,3.43907018360262,CCL14;CX3CR1;CXCL6;CCL13;IL20;IL37;IL24;TNFRSF10C;IL20RB;IL19;CXCL1;PPBP;CXCL13;IL2;CCR9;XCL1;ACKR3;IL6ST;CCL17;CCL15;CCL26
60,KEGG_2021_Human,Synaptic vesicle cycle,17/78,0.0920079178725818,0.467581221975416,0,0,1.5094057707029909,3.6012620089474594,UNC13B;UNC13A;STXBP1;SLC1A1;CACNA1B;SLC6A11;SLC1A6;SLC6A2;CPLX1;SLC1A7;SLC6A3;DNM3;RIMS1;CLTCL1;SLC17A7;AP2M1;SLC18A3
61,KEGG_2021_Human,Ferroptosis,10/41,0.0955117326597579,0.4775586632987899,0,0,1.74630981010034,4.101219388140301,GCLC;TF;TFRC;MAP1LC3C;ALOX15;ACSL5;SLC39A8;SLC7A11;GCLM;CP
62,KEGG_2021_Human,Folate biosynthesis,7/26,0.098562120486467,0.4825010571434132,0,0,1.9939680662329984,4.620160127198111,TPH2;AKR1B10;PAH;AKR1C3;GGH;ALPI;ALPG
63,KEGG_2021_Human,Melanogenesis,21/101,0.0996131214747691,0.4825010571434132,0,0,1.421952595936795,3.279678748644587,WNT10B;WNT2B;CALML5;FZD4;WNT3A;FZD7;WNT7B;WNT5A;FZD6;LEF1;CALML3;ADCY2;FZD10;ADCY8;POMC;WNT6;WNT11;CREB3L3;CREB3L1;DVL3;HRAS
64,KEGG_2021_Human,Thyroid hormone synthesis,16/75,0.1157726292889893,0.5521463858397956,0,0,1.4684754493762755,3.1662197175284312,GPX2;ATP1B3;ADCY2;LRP2;ATP1B1;ADCY8;SERPINA7;SLC5A5;TTR;TG;CREB3L3;IYD;CREB3L1;ALB;CGA;SLC26A4
65,KEGG_2021_Human,Vascular smooth muscle contraction,26/133,0.1292489133278752,0.6070782292672928,0,0,1.316277862300466,2.693124478348485,CALCA;CALML5;NPR1;PLA2G1B;PLA2G3;CALML3;CACNA1D;ADM;ADRA1D;ADCY2;ADRA1B;ADCY8;MYLK3;NPPC;KCNMB2;PLA2G2F;PLA2G12B;AVPR1B;EDN3;PLA2G2C;PLA2G4B;PLA2G4A;AGT;PLA2G10;AGTR1;RAMP1
66,KEGG_2021_Human,Proximal tubule bicarbonate reclamation,6/23,0.1371725320586455,0.6229866229282204,0,0,1.909801404515593,3.793850640845937,SLC9A3;CA4;ATP1B3;ATP1B1;SLC4A4;AQP1
67,KEGG_2021_Human,Hippo signaling pathway,31/163,0.1374210344485139,0.6229866229282204,0,0,1.2723302255816005,2.525201205920525,WNT2B;LEF1;PARD6G;FZD10;GLI2;SOX2;WNT6;PARD6B;CCND2;WNT11;DVL3;WNT10B;FZD4;WNT3A;FZD7;WNT7B;WNT5A;FZD6;BMP7;GDF5;FRMD1;BMP6;BMP5;TGFBR2;DLG1;FRMD6;PPP2R2C;PPP2R2B;SNAI2;BIRC5;TP73
68,KEGG_2021_Human,Tight junction,32/169,0.1386647644582168,0.6229866229282204,0,0,1.2654713816644223,2.5001867789263916,PARD6G;CACNA1D;CD1E;GATA4;CLDN2;CD1C;CLDN1;CD1B;CD1A;PRKAG3;CLDN20;PARD6B;TUBA3C;CLDN24;CLDN23;CGNL1;CGN;CLDN6;CLDN11;DLG1;OCLN;CLDN3;PPP2R2C;CLDN9;PPP2R2B;CLDN8;CLDN19;CLDN18;CLDN17;CLDN16;CFTR;TJP3
69,KEGG_2021_Human,PI3K-Akt signaling pathway,63/354,0.1427594313543019,0.6322203388547657,0,0,1.173913043478261,2.2851325137873046,CSF3R;EPO;ITGB4;LAMC2;FGF3;FGF4;GNGT1;COMP;GHR;CCND2;FGF8;CREB3L3;FGF9;IBSP;CREB3L1;MYB;KDR;HRAS;ITGA1;PGF;EREG;COL4A4;EIF4E1B;COL4A3;COL4A6;ITGA8;COL4A5;ITGA6;SGK1;SGK2;MET;ITGA9;TNXB;LAMA1;LPAR3;EFNA5;THBS4;NTF4;ERBB4;NTF3;CHAD;EIF4EBP1;FGF20;NGFR;NTRK2;LAMB4;VEGFD;GNG11;G6PC1;IL2;EPOR;GH2;CDK6;LPAR5;PPP2R2C;PPP2R2B;FGF19;ITGA10;FGF18;COL9A1;COL9A3;FGFR3;FGFR2
70,KEGG_2021_Human,"Parathyroid hormone synthesis, secretion and action",21/106,0.1448525600005742,0.6324548394391271,0,0,1.337909972115257,2.5848940860246756,SLC34A3;SLC34A2;GCM1;KL;CASR;MEF2C;PDE4D;PDE4C;ARRB1;ADCY2;PLD1;ADCY8;PTHLH;NR4A2;MMP24;MMP13;CYP24A1;CREB3L3;MMP15;CREB3L1;SOST
71,KEGG_2021_Human,Breast cancer,28/147,0.1497046390317339,0.6445616402755209,0,0,1.2744971291684095,2.4203860264854464,NOTCH3;SHC3;WNT2B;LEF1;FZD10;FGF3;FGF4;WNT6;FGF8;WNT11;FGF9;HEY1;FGF20;DVL3;HRAS;JAG2;WNT10B;JAG1;FZD4;WNT3A;FZD7;WNT7B;WNT5A;FZD6;ESR1;CDK6;FGF19;FGF18
72,KEGG_2021_Human,Retrograde endocannabinoid signaling,28/148,0.1585166662257412,0.6707422054052428,0,0,1.2638009049773755,2.32778925222582,ND6;GABRB2;GABRB1;CACNA1B;NDUFA4L2;CACNA1D;ADCY2;ADCY8;GRM1;GABRR3;GNGT1;RIMS1;GABRR1;SLC17A7;NDUFV2;GABRE;GRIA4;GABRQ;GABRA1;GABRA5;KCNJ9;GABRA4;GABRA3;GABRG3;GNG11;GABRG2;MAPK12;MGLL
73,KEGG_2021_Human,Vitamin digestion and absorption,6/24,0.1601126554838321,0.6707422054052428,0,0,1.803594351732991,3.3039641190007107,CUBN;ABCC1;FOLH1;CBLIF;APOA1;APOB
74,KEGG_2021_Human,Ovarian steroidogenesis,11/51,0.1623023386397616,0.6708496663776816,0,0,1.4884120861459338,2.706371353989325,LHCGR;STAR;PLA2G4B;HSD17B1;AKR1C3;PLA2G4A;ADCY2;ADCY8;CGA;BMP6;CYP17A1
75,KEGG_2021_Human,Gastric cancer,28/149,0.1676151733075262,0.6807823558027208,0,0,1.2532814778804084,2.2384666996968923,SHC3;WNT2B;LEF1;FZD10;FGF3;FGF4;WNT6;FGF8;WNT11;FGF9;FGF20;DVL3;HRAS;WNT10B;JUP;FZD4;WNT3A;FZD7;REG4;WNT7B;WNT5A;FZD6;TGFBR2;FGF19;FGF18;CDH17;MET;FGFR2
76,KEGG_2021_Human,Nicotinate and nicotinamide metabolism,8/35,0.1690975528929338,0.6807823558027208,0,0,1.6033683008634838,2.849633603324675,NT5E;NMRK2;NT5C1A;QPRT;AOX1;NMNAT3;ENPP3;NMNAT2
77,KEGG_2021_Human,Mucin type O-glycan biosynthesis,8/36,0.1895662167367822,0.7534041947231088,0,0,1.5460133957243785,2.571046384317154,GALNT12;ST6GALNAC1;ST6GALNAC2;B3GNT6;B3GNT3;GCNT3;GALNTL6;GALNT8
78,KEGG_2021_Human,Synthesis and degradation of ketone bodies,3/10,0.195841963808048,0.7644201526926783,0,0,2.3181880639399073,3.779683358687533,BDH1;HMGCS1;HMGCS2
79,KEGG_2021_Human,Pertussis,15/76,0.1986531277012292,0.7644201526926783,0,0,1.330971312794483,2.151109250174964,CXCL6;CALML5;SFTPA2;NOS2;C4BPA;CALML3;C4BPB;MAPK12;C2;C4B;C3;C4A;IL1A;C5;SFTPA1
80,KEGG_2021_Human,Asthma,7/31,0.1997355882842159,0.7644201526926783,0,0,1.5780898876404494,2.541925402011835,HLA-DMA;HLA-DRB5;CD40LG;PRG2;FCER1A;HLA-DPA1;HLA-DQB1
81,KEGG_2021_Human,IL-17 signaling pathway,18/94,0.2069739351327679,0.7824624376970496,0,0,1.282029978296256,2.019405431431018,CXCL6;CSF2;IL25;MMP1;MMP3;CXCL1;MUC5B;MUC5AC;MAPK12;S100A7A;MMP13;DEFB4A;MAPK6;S100A9;CCL17;IL17C;S100A8;S100A7
82,KEGG_2021_Human,Aldosterone-regulated sodium reabsorption,8/37,0.2110122213352425,0.7881179351075323,0,0,1.4926140012845217,2.322267412719049,FXYD4;SCNN1B;SFN;ATP1B3;ATP1B1;SGK1;KCNJ1;NR3C2
83,KEGG_2021_Human,Ras signaling pathway,41/232,0.215434141748413,0.7916929529629786,0,0,1.162618038951792,1.7847349781973307,SHC3;CALML5;PLA2G1B;RASGRF1;PLA2G3;CALML3;EFNA5;PLD1;FGF3;FGF4;GNGT1;NTF4;HTR7;FGF8;FGF9;NTF3;KDR;FGF20;PAK3;HRAS;PAK5;PLA2G2F;NGFR;NTRK2;PLA2G12B;PLA2G2C;PLA2G4B;PLA2G4A;PLAAT3;VEGFD;GNG11;PGF;GRIN1;RASA4;FGF19;PLA2G10;FGF18;FGFR3;MET;FGFR2;PLA1A
84,KEGG_2021_Human,Mineral absorption,12/60,0.2183461964218353,0.7916929529629786,0,0,1.3528938906752412,2.058662671953222,SLC34A3;SLC34A2;SLC9A3;S100G;TF;HEPHL1;TRPV6;MT1X;ATP1B3;SLC26A9;ATP1B1;CLCN2
85,KEGG_2021_Human,Type I diabetes mellitus,9/43,0.2196309482413424,0.7916929529629786,0,0,1.4322858600555546,2.171068430249854,IL1A;HLA-DMA;HLA-DRB5;PTPRN2;ICA1;GAD2;IL2;HLA-DPA1;HLA-DQB1
86,KEGG_2021_Human,"Phenylalanine, tyrosine and tryptophan biosynthesis",2/6,0.2379128195418866,0.8262453037412306,0,0,2.7041666666666666,3.882780349932015,PAH;TAT
87,KEGG_2021_Human,Phosphonate and phosphinate metabolism,2/6,0.2379128195418866,0.8262453037412306,0,0,2.7041666666666666,3.882780349932015,PCYT1B;PCYT1A
88,KEGG_2021_Human,Vitamin B6 metabolism,2/6,0.2379128195418866,0.8262453037412306,0,0,2.7041666666666666,3.882780349932015,PSAT1;AOX1
89,KEGG_2021_Human,Taurine and hypotaurine metabolism,3/11,0.2398776688280992,0.8262453037412306,0,0,2.0282943251042003,2.8956461174049237,GADL1;GAD2;BAAT
90,KEGG_2021_Human,Pathways in cancer,89/531,0.246037095193542,0.8297185494848776,0,0,1.0911675938731271,1.5301148127512845,RET;CSF3R;WNT2B;CALML5;EPO;HHIP;SLC2A1;CALML3;LAMC2;FZD10;GLI1;FGF3;GLI2;FGF4;GNGT1;FGF8;CCND2;HEY1;FGF9;SKP2;HRAS;DAPK1;DCC;MMP1;WNT5A;F2;KIF7;PGF;TGFBR2;CCNA1;SMO;COL4A4;COL4A3;AGTR1;COL4A6;BIRC5;COL4A5;ITGA6;BIRC7;IL6ST;MET;NOTCH3;LAMA1;PTGER2;LEF1;ADCY2;LPAR3;ADCY8;PLD1;CSF2RA;KNG1;WNT6;WNT11;FGF20;DVL3;IL12RB2;GSTM4;JAG2;GSTM3;WNT10B;GSTM2;GSTM1;JAG1;JUP;NOS2;FZD4;WNT3A;FZD7;WNT7B;ZBTB16;FZD6;LAMB4;VEGFD;GNG11;ESR1;AGT;IL2;EPOR;CDK6;RAD51;GSTA5;LPAR5;GSTA2;FGF19;GSTA1;FGF18;FGFR3;FGFR2;GSTM5
91,KEGG_2021_Human,Arginine and proline metabolism,10/50,0.246239053395512,0.8297185494848776,0,0,1.3526670951156812,1.895698618723793,AOC1;ALDH2;NOS2;ARG1;CKMT1A;CARNS1;CKMT1B;NOS1;PRODH;PRODH2
92,KEGG_2021_Human,Glycosphingolipid biosynthesis,9/45,0.2623142081295352,0.8655895923094954,0,0,1.3525538066174108,1.8100040404709457,FUT9;B3GALT2;B3GNT5;B3GNT3;ST3GAL5;B4GALNT1;A4GALT;B4GALT4;ST6GALNAC6
93,KEGG_2021_Human,Inflammatory mediator regulation of TRP channels,18/98,0.2630379872403641,0.8655895923094954,0,0,1.217638530927835,1.6261036792756742,CALML5;TRPA1;PLA2G4B;PTGER2;HTR2B;TRPV3;HTR2C;PLA2G4A;CALML3;ALOX12;ADCY2;IL1RAP;ADCY8;KNG1;MAPK12;TRPV4;TRPM8;ASIC1
94,KEGG_2021_Human,Butanoate metabolism,6/28,0.2652613266754905,0.8655895923094954,0,0,1.4753180067685845,1.9578057133952431,ACSM3;HMGCS1;BDH1;ACSM1;GAD2;HMGCS2
95,KEGG_2021_Human,Relaxin signaling pathway,23/129,0.2764649900604787,0.8927515304036291,0,0,1.1743167302903554,1.5097850639001462,SHC3;NOS2;MMP1;ARRB1;ADCY2;VEGFD;ADCY8;GNG11;RXFP2;MAPK12;TGFBR2;GNGT1;MMP13;CREB3L3;CREB3L1;COL4A4;COL4A3;COL4A6;COL4A5;RLN3;NOS1;HRAS;INSL5
96,KEGG_2021_Human,Cholinergic synapse,20/113,0.3064388342387228,0.9793406042680832,0,0,1.1636613215199352,1.3763054232526806,KCNJ4;CHRM3;ACHE;CHRNB4;CHRNA4;CHRNA7;CHRNA6;CACNA1B;CACNA1D;ADCY2;ADCY8;GNG11;GNGT1;SLC5A7;CREB3L3;CREB3L1;KCNQ1;KCNQ3;HRAS;SLC18A3
97,KEGG_2021_Human,Pentose phosphate pathway,6/30,0.323217905507652,0.9999957399330064,0,0,1.352214377406932,1.52722952784415,TKTL1;RGN;PGM2;ALDOC;ALDOB;FBP1
98,KEGG_2021_Human,Dilated cardiomyopathy,17/96,0.3253545248453913,0.9999957399330064,0,0,1.1642430542815794,1.307258491210382,ITGB4;LAMA1;CACNA2D1;TNNC1;ITGA1;CACNA2D3;CACNA2D2;ADCY2;CACNA1D;ADCY8;AGT;CACNG6;ITGA10;ITGA8;ITGA6;SGCG;ITGA9
99,KEGG_2021_Human,Hypertrophic cardiomyopathy,16/90,0.3266278918335372,0.9999957399330064,0,0,1.1697673204434311,1.3088920777570532,ITGB4;LAMA1;CACNA2D1;TNNC1;ITGA1;CACNA2D3;CACNA2D2;CACNA1D;PRKAG3;AGT;CACNG6;ITGA10;ITGA8;ITGA6;SGCG;ITGA9
100,KEGG_2021_Human,Graft-versus-host disease,8/42,0.3292291867237387,0.9999957399330064,0,0,1.2727341418262874,1.4140091010164475,IL1A;HLA-DMA;HLA-DRB5;KIR2DL1;KIR3DL2;IL2;HLA-DPA1;HLA-DQB1
101,KEGG_2021_Human,Intestinal immune network for IgA production,9/48,0.330409119783291,0.9999957399330064,0,0,1.2482888136598385,1.3823845361354412,PIGR;HLA-DMA;HLA-DRB5;CD40LG;TNFSF13;CCR9;IL2;HLA-DPA1;HLA-DQB1
102,KEGG_2021_Human,Focal adhesion,34/201,0.3325634994405644,0.9999957399330064,0,0,1.1017615029009338,1.2129561891269416,TNXB;SHC3;ITGB4;LAMA1;RASGRF1;LAMC2;MYLK3;THBS4;COMP;CCND2;IBSP;CHAD;KDR;PAK3;HRAS;PAK5;VAV3;CAV3;ITGA1;LAMB4;VEGFD;PGF;MYL7;COL4A4;ITGA10;COL4A3;COL9A1;COL4A6;ITGA8;COL4A5;COL9A3;ITGA6;MET;ITGA9
103,KEGG_2021_Human,Sphingolipid metabolism,9/49,0.3538226251573765,0.9999957399330064,0,0,1.2170093157725663,1.264423451423271,SMPD3;CERS3;NEU2;ACER1;ASAH1;GAL3ST1;SPTLC3;SPHK1;SGMS2
104,KEGG_2021_Human,Aldosterone synthesis and secretion,17/98,0.3581923930797462,0.9999957399330064,0,0,1.1353611260213514,1.1656582672994829,CALML5;NPR1;CALML3;ATP1B3;CACNA1D;ADCY2;ATP1B1;ADCY8;AGT;NR4A2;POMC;MC2R;CREB3L3;STAR;CYP21A2;CREB3L1;AGTR1
105,KEGG_2021_Human,Insulin secretion,15/86,0.3630449788554746,0.9999957399330064,0,0,1.1428305915311632,1.1579485759535777,CHRM3;SLC2A1;PDX1;ATP1B3;ADCY2;CACNA1D;ATP1B1;ADCY8;GCK;GIP;RIMS2;CREB3L3;CREB3L1;KCNMB2;KCNN4
106,KEGG_2021_Human,Cysteine and methionine metabolism,9/50,0.3774385256463742,0.9999957399330064,0,0,1.1872556470505278,1.1567996541070549,AHCYL2;BHMT;GCLC;AGXT2;PSAT1;TAT;BHMT2;PHGDH;GCLM
107,KEGG_2021_Human,Hepatocellular carcinoma,28/168,0.3842411088888039,0.9999957399330064,0,0,1.0819650937297995,1.0348834213046565,SHC3;WNT2B;LEF1;FZD10;WNT6;WNT11;DPF1;DVL3;HRAS;GSTM4;GSTM3;WNT10B;GSTM2;GSTM1;FZD4;WNT3A;FZD7;WNT7B;WNT5A;FZD6;ACTL6A;TGFBR2;CDK6;GSTA5;GSTA2;GSTA1;MET;GSTM5
108,KEGG_2021_Human,Axon guidance,30/182,0.4030597449205285,0.9999957399330064,0,0,1.0676533669231294,0.9701450948336238,NRP1;SEMA3D;SEMA3B;LRRC4;PARD6G;SEMA3E;SEMA3F;EFNA5;NTN1;RND1;PARD6B;DPYSL2;PAK3;EPHB1;HRAS;PAK5;EPHB3;EPHA7;TRPC5;EPHA6;SEMA6A;TRPC6;EPHA8;DCC;SEMA6D;WNT5A;BMP7;RGMA;SMO;MET
109,KEGG_2021_Human,Fructose and mannose metabolism,6/33,0.4125031455678669,0.9999957399330064,0,0,1.2017543859649122,1.0641672659963552,AKR1B10;HKDC1;ALDOC;ALDOB;FBP1;HK2
110,KEGG_2021_Human,GnRH secretion,11/64,0.4153142386886934,0.9999957399330064,0,0,1.1224625946883549,0.9863301556788796,GABBR2;TRPC5;KCNJ9;KISS1R;GNRH2;ARRB1;CACNA1D;CGA;KCNN4;HRAS;HCN1
111,KEGG_2021_Human,Fluid shear stress and atherosclerosis,23/139,0.4154269293853585,0.9999957399330064,0,0,1.0724427234591805,0.9420857468447422,GSTM4;GSTM3;MEF2C;GSTM2;GSTM1;CALML5;CAV3;IL1R2;CALML3;SELE;KLF2;MAPK12;ICAM1;NPPC;THBD;IL1A;GSTA5;TRPV4;GPC1;GSTA2;GSTA1;KDR;GSTM5
112,KEGG_2021_Human,Leukocyte transendothelial migration,19/114,0.416584058114421,0.9999957399330064,0,0,1.081727360618756,0.9472329716595804,VAV3;CLDN2;CLDN1;MAPK12;ICAM1;CLDN6;CLDN11;OCLN;CLDN20;CLDN3;MYL7;CLDN9;CLDN8;CLDN24;CLDN23;CLDN19;CLDN18;CLDN17;CLDN16
113,KEGG_2021_Human,Pantothenate and CoA biosynthesis,4/21,0.4197902703291874,0.9999957399330064,0,0,1.2723842583858431,1.104429598350535,ALDH2;DPYS;GADL1;ENPP3
114,KEGG_2021_Human,Thiamine metabolism,3/15,0.4223617254082121,0.9999957399330064,0,0,1.351875601154216,1.1651723377154473,AK1;ALPI;ALPG
115,KEGG_2021_Human,Type II diabetes mellitus,8/46,0.430207834545938,0.9999957399330064,0,0,1.1384917013149445,0.960302779929856,HKDC1;CACNA1B;IRS4;PDX1;CACNA1D;MAFA;HK2;GCK
116,KEGG_2021_Human,Circadian entrainment,16/97,0.4474575863571547,0.9999957399330064,0,0,1.068231141637452,0.8590432025242809,CALML5;KCNJ9;CALML3;CACNA1D;ADCY2;ADCY8;GNG11;RYR3;GRIN1;GNGT1;ADCY10;MTNR1A;RASD1;PRKG2;NOS1;GRIA4
117,KEGG_2021_Human,Endocrine and other factor-regulated calcium reabsorption,9/53,0.4486040579162148,0.9999957399330064,0,0,1.1061092778086032,0.8866733586786519,DNM3;KL;CALB1;CLTCL1;ATP1B3;KLK2;ATP1B1;ESR1;AP2M1
118,KEGG_2021_Human,Phototransduction,5/28,0.4491178373365727,0.9999957399330064,0,0,1.1755310987432177,0.940977357117034,GNGT1;GRK1;CALML5;GRK7;CALML3
119,KEGG_2021_Human,Alcoholism,30/186,0.4533857784051215,0.9999957399330064,0,0,1.0400288585928947,0.822675211761844,SHC3;CALML5;CALML3;MACROH2A2;SLC6A3;H2AC11;GNGT1;H2AC12;H3C15;CREB3L3;CREB3L1;NPY;H3C1;H4C2;H4C1;DRD2;H2BW1;H2BW2;HRAS;H3C7;H2BC9;H3C8;NTRK2;H2AC8;H2BC3;GNG11;GRIN1;PPP1R1B;H2BC11;CRH
120,KEGG_2021_Human,cGMP-PKG signaling pathway,27/167,0.4537077954150179,0.9999957399330064,0,0,1.0429863835679667,0.8242741316515598,OPRD1;CALML5;NPR1;IRS4;CALML3;CACNA1D;GATA4;ADRA1D;ADCY2;ADRA1B;ADCY8;MYLK3;KNG1;NPPC;CREB3L3;CREB3L1;KCNMB2;ADORA1;PRKG2;MEF2C;TRPC6;ATP1B3;ATP1B1;ADRA2B;ADRA2A;AGTR1;PPIF
121,KEGG_2021_Human,Arginine biosynthesis,4/22,0.4570247279124922,0.9999957399330064,0,0,1.2016249732734658,0.9408937193665826,NOS2;CPS1;ARG1;NOS1
122,KEGG_2021_Human,Apelin signaling pathway,22/137,0.4785382680965658,0.9999957399330064,0,0,1.034462833099579,0.7624188622658146,NOTCH3;MEF2C;JAG1;CALML5;NOS2;SPHK1;BECN2;UCP1;CALML3;ADCY2;ADCY8;GNG11;MYLK3;PRKAG3;RYR3;KLF2;GNGT1;ADCY10;AGTR1;NOS1;PPARGC1A;HRAS
123,KEGG_2021_Human,Adrenergic signaling in cardiomyocytes,24/150,0.4821288628022384,0.9999957399330064,0,0,1.0299732546343263,0.7514106540476018,CALML5;CACNA2D1;TNNC1;CACNA2D3;CACNA2D2;CALML3;ATP1B3;CACNA1D;ADRA1D;ADCY2;ATP1B1;ADRA1B;ADCY8;AGT;MAPK12;CACNG6;CREB3L3;PPP2R2C;PPP2R2B;CREB3L1;KCNQ1;AGTR1;SCN7A;AGTR2
124,KEGG_2021_Human,Tryptophan metabolism,7/42,0.4897327236657517,0.9999957399330064,0,0,1.0814125200642055,0.7720155302062854,TPH2;AOC1;ALDH2;AOX1;ALDH8A1;INMT;ACMSD
125,KEGG_2021_Human,Primary bile acid biosynthesis,3/17,0.5087809997812374,0.9999957399330064,0,0,1.158613108597078,0.7829184539037533,ACOX2;BAAT;CYP8B1
126,KEGG_2021_Human,Hedgehog signaling pathway,9/56,0.5185119134738486,0.9999957399330064,0,0,1.035322019533733,0.6799915043296915,CCND2;SMO;HHIP;IHH;ARRB1;LRP2;GLI1;KIF7;GLI2
127,KEGG_2021_Human,Wnt signaling pathway,26/166,0.5256545771613162,0.9999957399330064,0,0,1.0040328534514582,0.6457045517094154,WNT2B;CTNND2;LEF1;FZD10;CXXC4;WNT6;CCND2;WNT11;TBL1Y;DVL3;RSPO1;SOST;WNT10B;TLE2;FZD4;WNT3A;FZD7;WNT7B;WNT5A;FZD6;DKK4;SFRP1;VANGL2;DAAM2;ROR1;LGR5
128,KEGG_2021_Human,Ubiquinone and other terpenoid-quinone biosynthesis,2/11,0.5308930644572393,0.9999957399330064,0,0,1.2014957264957264,0.7607806819033689,COQ3;TAT
129,KEGG_2021_Human,Prolactin signaling pathway,11/70,0.5410988207396258,0.9999957399330064,0,0,1.0079542792387863,0.6190385009827216,LHCGR;CCND2;SHC3;CISH;CSN2;CGA;HRAS;ESR1;GCK;MAPK12;CYP17A1
130,KEGG_2021_Human,Allograft rejection,6/38,0.5563948132838508,0.9999957399330064,0,0,1.0136793966623876,0.5942970584604568,HLA-DMA;HLA-DRB5;CD40LG;IL2;HLA-DPA1;HLA-DQB1
131,KEGG_2021_Human,Choline metabolism in cancer,15/98,0.5760485803468383,0.9999957399330064,0,0,0.9769040759109822,0.5388244172954036,SLC22A3;SLC44A3;PCYT1B;SLC44A4;PCYT1A;DGKA;SLC22A2;PLA2G4B;SLC22A1;PLA2G4A;PLD1;SLC5A7;EIF4EBP1;WASF1;HRAS
132,KEGG_2021_Human,Notch signaling pathway,9/59,0.5852539368439567,0.9999957399330064,0,0,0.9730292322518472,0.5212609508158427,LFNG;JAG2;NOTCH3;TLE2;JAG1;HEY1;PSEN2;DVL3;DTX4
133,KEGG_2021_Human,Rap1 signaling pathway,32/210,0.5887706810470141,0.9999957399330064,0,0,0.9716010326897204,0.5146750486543649,CALML5;PARD6G;CALML3;LPAR3;ADCY2;ADCY8;EFNA5;FGF3;RAP1GAP;FGF4;PARD6B;FGF8;FGF9;P2RY1;KDR;FGF20;DRD2;HRAS;VAV3;NGFR;MAGI3;VEGFD;PGF;MAPK12;GRIN1;LPAR5;FGF19;FGF18;FGFR3;MET;FGFR2;PFN2
134,KEGG_2021_Human,"Growth hormone synthesis, secretion and action",18/119,0.5969209635093351,0.9999957399330064,0,0,0.9632604368684292,0.4970140306831632,GHSR;SHC3;IRS4;CACNA1D;ADCY2;SSTR1;SSTR2;ADCY8;MAPK12;GH2;GHR;ADCY10;CREB3L3;SST;CREB3L1;GHRH;IGFALS;HRAS
135,KEGG_2021_Human,Autoimmune thyroid disease,8/53,0.5994255518471866,0.9999957399330064,0,0,0.960993363305502,0.4918205430737166,HLA-DMA;HLA-DRB5;CD40LG;TG;CGA;IL2;HLA-DPA1;HLA-DQB1
136,KEGG_2021_Human,Viral myocarditis,9/60,0.6065325822080674,0.9999957399330064,0,0,0.9538935394266926,0.4769437462007863,HLA-DMA;HLA-DRB5;CD40LG;LAMA1;SGCG;CD55;ICAM1;HLA-DPA1;HLA-DQB1
137,KEGG_2021_Human,Transcriptional misregulation in cancer,29/192,0.6075994474859626,0.9999957399330064,0,0,0.9614724719780864,0.4790434844761928,CSF2;HPGD;TMPRSS2;HOXA11;HOXA10;H3C15;CCND2;H3C1;PROM1;ELANE;H3C7;NGFR;H3C8;MEF2C;BCL11B;JUP;IL1R2;ZBTB16;DEFA5;MMP3;PAX3;DUSP6;TGFBR2;BAIAP3;CCNA1;TLX3;PAX7;TLX1;MET
138,KEGG_2021_Human,"Glycine, serine and threonine metabolism",6/40,0.6092533919298381,0.9999957399330064,0,0,0.953937929472174,0.4726962949763528,DMGDH;BHMT;AGXT2;PSAT1;CHDH;PHGDH
139,KEGG_2021_Human,Human papillomavirus infection,50/331,0.6239862471653457,0.9999957399330064,0,0,0.9613290517497034,0.4533886892525011,WNT2B;ITGB4;LAMC2;FZD10;LFNG;COMP;CCND2;CREB3L3;HEY1;IBSP;CREB3L1;HRAS;WNT5A;ITGA1;CCNA1;COL4A4;COL4A3;COL4A6;ITGA8;COL4A5;ITGA6;TLR3;ITGA9;NOTCH3;TNXB;LAMA1;PARD6G;THBS4;WNT6;PARD6B;WNT11;CHAD;EIF4EBP1;DVL3;HES2;WNT10B;JAG1;FZD4;WNT3A;FZD7;WNT7B;FZD6;LAMB4;DLG1;CDK6;PPP2R2C;PPP2R2B;ITGA10;COL9A1;COL9A3
140,KEGG_2021_Human,Steroid biosynthesis,3/20,0.6242260487023457,0.9999957399330064,0,0,0.9539822341248138,0.449557181577885,CYP24A1;CEL;DHCR7
141,KEGG_2021_Human,Biosynthesis of unsaturated fatty acids,4/27,0.6265955261578106,0.9999957399330064,0,0,0.9401232674233762,0.4394644197925355,ELOVL4;ELOVL2;SCD5;BAAT
142,KEGG_2021_Human,JAK-STAT signaling pathway,24/162,0.6433318462241533,0.9999957399330064,0,0,0.939736716535212,0.4145127885694188,CNTFR;IL11;CSF2;CSF3R;IL20;CISH;TSLP;EPO;IL24;IL20RB;IL19;CSF2RA;IL2;EPOR;GH2;GHR;CCND2;THPO;IFNK;AOX1;IL6ST;HRAS;IL12RB2;CRLF2
143,KEGG_2021_Human,Cocaine addiction,7/49,0.660901890217527,0.9999957399330064,0,0,0.9008025682182984,0.3730672723280099,CREB3L3;CREB3L1;PPP1R1B;DRD2;SLC6A3;GRIN1;CDK5R1
144,KEGG_2021_Human,Central carbon metabolism in cancer,10/70,0.6700995143516483,0.9999957399330064,0,0,0.900706940874036,0.3605791528366722,RET;SLC7A5;HKDC1;SLC2A1;HRAS;MET;FGFR3;HK2;GCK;FGFR2
145,KEGG_2021_Human,Malaria,7/50,0.6823012932456369,0.9999957399330064,0,0,0.879801411026914,0.3363339495976918,COMP;GYPA;CD40LG;MET;SELE;THBS4;ICAM1
146,KEGG_2021_Human,Dopaminergic synapse,19/132,0.6864048195779263,0.9999957399330064,0,0,0.9084414454752608,0.3418353505541758,CALML5;KCNJ9;CACNA1B;CALML3;CACNA1D;ARRB1;GNG11;SLC6A3;MAPK12;GNGT1;CREB3L3;CALY;PPP2R2C;PPP2R2B;CREB3L1;PPP1R1B;DRD2;SCN1A;GRIA4
147,KEGG_2021_Human,Sphingolipid signaling pathway,17/119,0.6930263788949831,0.9999957399330064,0,0,0.9004830917874396,0.3301956377423183,CERS3;OPRD1;ABCC1;ASAH1;SPHK1;SGMS2;PLD1;KNG1;MAPK12;ACER1;PPP2R2C;SPTLC3;PPP2R2B;ADORA1;FCER1A;S1PR5;HRAS
148,KEGG_2021_Human,Melanoma,10/72,0.7051898409711275,0.9999957399330064,0,0,0.8715482212455428,0.304421539432923,FGF8;CDK6;FGF9;FGF19;FGF18;FGF20;HRAS;MET;FGF3;FGF4
149,KEGG_2021_Human,"Alanine, aspartate and glutamate metabolism",5/37,0.7057735318457794,0.9999957399330064,0,0,0.8444618222649984,0.2942619007371354,FOLH1;CPS1;AGXT2;GAD2;ASRGL1
150,KEGG_2021_Human,mTOR signaling pathway,22/154,0.7082987159395603,0.9999957399330064,0,0,0.9003225806451612,0.3105116778226197,WNT10B;WNT2B;FZD4;WNT3A;FZD7;WNT7B;WNT5A;FZD6;FZD10;WNT6;SLC7A5;DEPTOR;WNT11;RPS6KA2;EIF4E1B;EIF4EBP1;DVL3;SKP2;SGK1;HRAS;FNIP2;LPIN2
151,KEGG_2021_Human,Rheumatoid arthritis,13/93,0.7106149220069252,0.9999957399330064,0,0,0.877991315535542,0.2999434288566984,CXCL6;IL11;HLA-DRB5;CSF2;MMP1;MMP3;TNFSF13;CXCL1;ICAM1;IL1A;HLA-DMA;HLA-DPA1;HLA-DQB1
152,KEGG_2021_Human,AGE-RAGE signaling pathway in diabetic complications,14/100,0.712720203204298,0.9999957399330064,0,0,0.8795306934841819,0.2978674562355081,VEGFD;SELE;AGT;MAPK12;ICAM1;TGFBR2;THBD;IL1A;COL4A4;COL4A3;AGTR1;COL4A6;COL4A5;HRAS
153,KEGG_2021_Human,p53 signaling pathway,10/73,0.7218205008619245,0.9999957399330064,0,0,0.857663116660546,0.2795799805054664,TP53AIP1;CCNB2;CCND2;CDK6;SESN3;PERP;SFN;SERPINB5;RPRM;TP73
154,KEGG_2021_Human,Primary immunodeficiency,5/38,0.7284066473989277,0.9999957399330064,0,0,0.8188234607868872,0.2594817198753376,CD40LG;AIRE;CD8B2;ADA;RAG1
155,KEGG_2021_Human,Purine metabolism,18/129,0.7340393401052087,0.9999957399330064,0,0,0.8759577876845918,0.2708397139810721,GUCY2C;PDE1C;GDA;NPR1;PDE4D;AK1;PDE4C;GMPS;ENTPD8;ADCY2;ADCY8;ADCY10;NT5E;NT5C1A;PGM2;ENPP4;ENPP3;ADA
156,KEGG_2021_Human,Long-term depression,8/60,0.7392048455400845,0.9999957399330064,0,0,0.831283039375525,0.2511972780564639,PPP1R17;PLA2G4B;CRH;PRKG2;PLA2G4A;NOS1;HRAS;GRM1
157,KEGG_2021_Human,Longevity regulating pathway,14/102,0.7403721650082031,0.9999957399330064,0,0,0.8594389844389845,0.258349329864489,KL;IRS4;ADCY2;ADCY8;PRKAG3;CREB3L3;SESN3;CREB3L1;EIF4E1B;EIF4EBP1;PPARGC1A;HRAS;CRYAB;FOXA2
158,KEGG_2021_Human,Riboflavin metabolism,1/8,0.7428320476077649,0.9999957399330064,0,0,0.7722341740284707,0.229573872810818,ENPP3
159,KEGG_2021_Human,Glycerolipid metabolism,8/61,0.7561034002010257,0.9999957399330064,0,0,0.8155499812169024,0.2280091307883553,AKR1B10;ALDH2;DGKA;LPL;CEL;LPIN2;MGLL;PNLIPRP3
160,KEGG_2021_Human,Other types of O-glycan biosynthesis,6/47,0.7633284150123845,0.9999957399330064,0,0,0.7907417264159805,0.2135531780914161,GALNT12;LFNG;COLGALT2;GALNTL6;XXYLT1;GALNT8
161,KEGG_2021_Human,Adipocytokine signaling pathway,9/69,0.7696605010898733,0.9999957399330064,0,0,0.810375843238034,0.2121610708489669,POMC;NPY;IRS4;SLC2A1;ACSL5;AGRP;PPARGC1A;G6PC1;PRKAG3
162,KEGG_2021_Human,Amphetamine addiction,9/69,0.7696605010898733,0.9999957399330064,0,0,0.810375843238034,0.2121610708489669,CALML5;CREB3L3;CREB3L1;PPP1R1B;CALML3;CACNA1D;SLC6A3;GRIA4;GRIN1
163,KEGG_2021_Human,Amino sugar and nucleotide sugar metabolism,6/48,0.7811398357453171,0.9999957399330064,0,0,0.7718686961305703,0.1906524155490117,CYB5R2;CHIA;HKDC1;PGM2;HK2;GCK
164,KEGG_2021_Human,"Valine, leucine and isoleucine degradation",6/48,0.7811398357453171,0.9999957399330064,0,0,0.7718686961305703,0.1906524155490117,ACAD8;ALDH2;HMGCS1;AGXT2;AOX1;HMGCS2
165,KEGG_2021_Human,Bladder cancer,5/41,0.7886427019224552,0.9999957399330064,0,0,0.7504544968452572,0.1781893490824541,DAPK1;MMP1;HRAS;UPK3A;FGFR3
166,KEGG_2021_Human,Pyrimidine metabolism,7/56,0.7919091588786727,0.9999957399330064,0,0,0.7717954597569365,0.1800665121294427,CDA;NT5E;UCK2;DPYS;NT5C1A;ENTPD8;ENPP3
167,KEGG_2021_Human,Small cell lung cancer,12/92,0.7919818929105457,0.9999957399330064,0,0,0.810192926045016,0.1889505610169475,CDK6;NOS2;LAMA1;COL4A4;COL4A3;LAMB4;COL4A6;COL4A5;LAMC2;ITGA6;BIRC7;SKP2
168,KEGG_2021_Human,Fatty acid biosynthesis,2/18,0.7961061385578765,0.9999957399330064,0,0,0.6755608974358974,0.1540432618202861,OLAH;ACSL5
169,KEGG_2021_Human,Other glycan degradation,2/18,0.7961061385578765,0.9999957399330064,0,0,0.6755608974358974,0.1540432618202861,NEU2;FUCA1
170,KEGG_2021_Human,Pathogenic Escherichia coli infection,27/197,0.7973758407556345,0.9999957399330064,0,0,0.8573904780005702,0.1941381903065855,WIPF3;CLDN2;CLDN1;CLDN20;TUBB6;TUBA3C;CLDN24;CLDN23;PAK3;WASF1;F2;MAPK12;CLDN6;CLDN11;OCLN;CLDN3;LPAR5;CLDN9;MYO1A;CLDN8;MYO5C;CLDN19;CLDN18;CLDN17;CLDN16;GAPDH;MYO1G
171,KEGG_2021_Human,Glutamatergic synapse,15/114,0.8009515427521059,0.9999957399330064,0,0,0.818240337068789,0.1816123946544148,PLA2G4B;SLC1A1;PLA2G4A;CACNA1D;ADCY2;PLD1;SLC1A6;ADCY8;SLC1A7;GNG11;GRM1;GRIN1;GNGT1;SLC17A7;GRIA4
172,KEGG_2021_Human,GnRH signaling pathway,12/93,0.804036244561675,0.9999957399330064,0,0,0.8001429081814934,0.1745199142513771,CALML5;PLA2G4B;GNRH2;PLA2G4A;CALML3;ADCY2;CACNA1D;ADCY8;PLD1;CGA;HRAS;MAPK12
173,KEGG_2021_Human,MAPK signaling pathway,41/294,0.8075622938876823,0.9999957399330064,0,0,0.8744465954152251,0.1868999154117912,RASGRF1;CACNA1B;HSPB1;CACNA1D;ARRB1;IL1RAP;EFNA5;FGF3;FGF4;NTF4;CACNG6;FGF8;FGF9;ERBB4;RPS6KA2;NTF3;KDR;FGF20;HRAS;DUSP4;NGFR;NTRK2;MEF2C;CACNA2D1;PLA2G4B;CACNA2D3;CACNA2D2;PLA2G4A;VEGFD;DUSP9;DUSP6;PGF;MAPK12;EREG;TGFBR2;IL1A;FGF19;FGF18;FGFR3;MET;FGFR2
174,KEGG_2021_Human,Hepatitis C,21/157,0.8104678146557501,0.9999957399330064,0,0,0.833654229186031,0.1751871417880816,CLDN2;CLDN1;CLDN6;CLDN11;OCLN;CLDN20;CLDN3;CDK6;PPP2R2C;CLDN9;PPP2R2B;CLDN8;CLDN24;CLDN23;IFIT1B;CLDN19;CLDN18;CLDN17;CLDN16;HRAS;TLR3
175,KEGG_2021_Human,TGF-beta signaling pathway,12/94,0.8155718077549994,0.9999957399330064,0,0,0.7903380127048859,0.1611228968761645,GREM2;LEFTY1;ACVR1C;AMHR2;FST;LEFTY2;BMP7;GDF5;BMP6;RGMA;TGFBR2;BMP5
176,KEGG_2021_Human,Inflammatory bowel disease,8/65,0.8158582302444299,0.9999957399330064,0,0,0.7581381198661393,0.1542922342506048,IL1A;HLA-DMA;HLA-DRB5;RORC;IL2;HLA-DPA1;HLA-DQB1;IL12RB2
177,KEGG_2021_Human,Sulfur metabolism,1/10,0.8168818275227433,0.9999957399330064,0,0,0.6005553775499306,0.1214688330511341,SELENBP1
178,KEGG_2021_Human,Cardiac muscle contraction,11/87,0.8178050300257013,0.9999957399330064,0,0,0.7816999103351435,0.157224335115236,CACNG6;COX8C;CACNA2D1;TNNC1;CACNA2D3;CACNA2D2;ATP1B3;CACNA1D;ATP1B1;COX6B2;TRDN
179,KEGG_2021_Human,Fatty acid degradation,5/43,0.822650676094732,0.9999957399330064,0,0,0.7108724650895767,0.1387790962063888,ADH4;ALDH2;ADH1B;ACSL5;ADH7
180,KEGG_2021_Human,Gap junction,11/88,0.829133195800401,0.9999957399330064,0,0,0.7715020434403269,0.1445597836437364,GJA1;TUBB6;TUBA3C;HTR2B;HTR2C;PRKG2;ADCY2;ADCY8;DRD2;HRAS;GRM1
181,KEGG_2021_Human,VEGF signaling pathway,7/59,0.8347572487165306,0.9999957399330064,0,0,0.7271391529818496,0.1313317411151334,PLA2G4B;SPHK1;KDR;HSPB1;PLA2G4A;HRAS;MAPK12
182,KEGG_2021_Human,DNA replication,4/36,0.8350164053022865,0.9999957399330064,0,0,0.6753527902501604,0.121768746858127,RNASEH2A;RFC4;MCM5;MCM2
183,KEGG_2021_Human,Vasopressin-regulated water reabsorption,5/44,0.8379191515689236,0.9999957399330064,0,0,0.6926038350484933,0.122475671771301,CREB3L3;CREB3L1;AQP4;AQP2;DYNC1I1
184,KEGG_2021_Human,Acute myeloid leukemia,8/67,0.8411889859815433,0.9999957399330064,0,0,0.7323514363780848,0.1266520726644227,CCNA1;CSF2;JUP;ZBTB16;LEF1;EIF4EBP1;HRAS;DUSP6
185,KEGG_2021_Human,Oxytocin signaling pathway,20/154,0.8445424877497728,0.9999957399330064,0,0,0.8056429650586526,0.1361216229857968,KCNJ4;MEF2C;CALML5;NPR1;KCNJ9;CACNA2D1;PLA2G4B;CACNA2D3;CACNA2D2;PLA2G4A;CALML3;CACNA1D;OXT;ADCY2;ADCY8;MYLK3;PRKAG3;RYR3;CACNG6;HRAS
186,KEGG_2021_Human,African trypanosomiasis,4/37,0.8506821781001411,0.9999957399330064,0,0,0.6548486792232783,0.1058999601398128,APOA1;SELE;KNG1;ICAM1
187,KEGG_2021_Human,Regulation of actin cytoskeleton,29/218,0.8508211147755587,0.9999957399330064,0,0,0.8279165961028231,0.133752723141524,CHRM3;ITGB4;FGF3;MYLK3;KNG1;FGF4;FGF8;SCIN;FGF9;FGF20;PAK3;WASF1;HRAS;PAK5;VAV3;ITGA1;F2;MYL7;LPAR5;FGF19;ITGA10;FGF18;ITGA8;ARHGEF4;ITGA6;FGFR3;FGFR2;PFN2;ITGA9
188,KEGG_2021_Human,Phospholipase D signaling pathway,19/148,0.8531349933399061,0.9999957399330064,0,0,0.7950070824183648,0.1262769270170924,PTGFR;SHC3;AVPR1B;DGKA;PLA2G4B;SPHK1;PLA2G4A;LPAR3;ADCY2;PLD1;F2;ADCY8;GRM1;AGT;DNM3;LPAR5;AGTR1;FCER1A;HRAS
189,KEGG_2021_Human,Glycosaminoglycan biosynthesis,6/53,0.855202353033958,0.9999957399330064,0,0,0.6895501597793133,0.1078574830709202,CHST7;HS3ST3A1;B3GNT7;HS6ST1;B4GALT4;CHST2
190,KEGG_2021_Human,Leishmaniasis,9/77,0.8683641016086505,0.9999957399330064,0,0,0.7146973791122617,0.1008753757917912,C3;IL1A;HLA-DMA;HLA-DRB5;NOS2;EEF1A2;MAPK12;HLA-DPA1;HLA-DQB1
191,KEGG_2021_Human,Glucagon signaling pathway,13/107,0.871360760478387,0.9999957399330064,0,0,0.7466038885048897,0.1028067557363042,CALML5;GCGR;PPP4R3C;SLC2A1;CALML3;ADCY2;G6PC1;PRKAG3;GCK;CREB3L3;CREB3L1;PPARGC1A;FBP1
192,KEGG_2021_Human,Pyruvate metabolism,5/47,0.8773455829367414,0.9999957399330064,0,0,0.6430175535084101,0.0841416202039509,ADH4;ALDH2;ADH1B;ME1;ADH7
193,KEGG_2021_Human,Terpenoid backbone biosynthesis,2/22,0.8789756275183129,0.9999957399330064,0,0,0.5403205128205129,0.0697003245114041,HMGCS1;HMGCS2
194,KEGG_2021_Human,Adherens junction,8/71,0.8835109641105857,0.9999957399330064,0,0,0.6856898186377955,0.0849237656729807,PTPRB;LEF1;SNAI2;LMO7;WASF1;MET;TGFBR2;NECTIN1
195,KEGG_2021_Human,HIF-1 signaling pathway,13/109,0.887053168470619,0.9999957399330064,0,0,0.7309625281440978,0.0876061196322658,TFRC;NOS2;EPO;SLC2A1;ENO3;HK2;TF;EIF4E1B;HKDC1;EIF4EBP1;ALDOC;ALDOB;GAPDH
196,KEGG_2021_Human,Neutrophil extracellular trap formation,24/189,0.8890016140944117,0.9999957399330064,0,0,0.784693937437643,0.0923241286883175,FGB;H2BC9;FGA;H3C8;H2AC8;H2BC3;FGG;AZU1;MACROH2A2;MAPK12;H2AC11;C3;H2AC12;C5;H3C15;H2BC11;PPIF;H3C1;H4C2;H4C1;H2BW1;H2BW2;ELANE;H3C7
197,KEGG_2021_Human,Non-homologous end-joining,1/13,0.8899793408037168,0.9999957399330064,0,0,0.4503364306312079,0.0524898764523311,DNTT
198,KEGG_2021_Human,Mannose type O-glycan biosynthesis,2/23,0.8941562088521251,0.9999957399330064,0,0,0.5145604395604395,0.0575663405071062,FUT9;B3GAT1
199,KEGG_2021_Human,Toxoplasmosis,13/112,0.9076487111916278,0.9999957399330064,0,0,0.7086854391453942,0.0686701004724759,HLA-DRB5;NOS2;LAMA1;LAMB4;LAMC2;MAPK12;HLA-DMA;CD40LG;PPIF;ITGA6;BIRC7;HLA-DPA1;HLA-DQB1
200,KEGG_2021_Human,AMPK signaling pathway,14/120,0.9108435811755562,0.9999957399330064,0,0,0.7127315995240524,0.0665577965404937,SCD5;IRS4;G6PC1;PRKAG3;CCNA1;CREB3L3;PPP2R2C;PPP2R2B;CREB3L1;HNF4A;EIF4EBP1;PPARGC1A;FBP1;CFTR
201,KEGG_2021_Human,Long-term potentiation,7/67,0.9153481490498876,0.9999957399330064,0,0,0.6298876404494382,0.0557140627536706,CALML5;RPS6KA2;CALML3;ADCY8;HRAS;GRM1;GRIN1
202,KEGG_2021_Human,Fc epsilon RI signaling pathway,7/68,0.9225282984065054,0.9999957399330064,0,0,0.6195247743599189,0.0499567603321171,VAV3;CSF2;PLA2G4B;FCER1A;PLA2G4A;HRAS;MAPK12
203,KEGG_2021_Human,Phagosome,18/152,0.9230414414650412,0.9999957399330064,0,0,0.7246114786890291,0.0580277182161093,HLA-DRB5;TFRC;SFTPA2;SFTPD;THBS4;COMP;C3;TUBB6;HLA-DMA;TUBA3C;MRC1;NOS1;SFTPA1;PLA2R1;DYNC1I1;HLA-DPA1;MBL2;HLA-DQB1
204,KEGG_2021_Human,Th1 and Th2 cell differentiation,10/92,0.924972953542788,0.9999957399330064,0,0,0.6581917361590068,0.0513328877550857,JAG2;NOTCH3;HLA-DMA;HLA-DRB5;JAG1;IL2;MAPK12;HLA-DPA1;HLA-DQB1;IL12RB2
205,KEGG_2021_Human,ErbB signaling pathway,9/85,0.929680705027562,0.9999957399330064,0,0,0.6391617495392835,0.0466038907552251,SHC3;NRG4;ERBB4;EIF4EBP1;NRG1;PAK3;HRAS;PAK5;EREG
206,KEGG_2021_Human,Glycosylphosphatidylinositol (GPI)-anchor biosynthesis,2/26,0.9297041111948992,0.9999957399330064,0,0,0.4501602564102564,0.0328116874727953,PGAP1;PIGX
207,KEGG_2021_Human,Proteoglycans in cancer,25/205,0.930402651683588,0.9999957399330064,0,0,0.7488429663114843,0.0540199049042656,WNT2B;IHH;TWIST1;FZD10;HOXD10;WNT6;WNT11;ERBB4;GPC1;KDR;GPC3;HRAS;VAV3;WNT10B;CAV3;FZD4;WNT3A;FZD7;WNT7B;FZD6;WNT5A;ESR1;MAPK12;SMO;MET
208,KEGG_2021_Human,Cell cycle,14/124,0.9321289548818896,0.9999957399330064,0,0,0.6866502866502866,0.04826060445749,BUB1B;TTK;PKMYT1;CDC25A;CCNB2;CCNA1;CCND2;ORC6;CDK6;CDC45;SFN;MCM5;SKP2;MCM2
209,KEGG_2021_Human,Collecting duct acid secretion,2/27,0.9387993476268046,0.9999957399330064,0,0,0.4321282051282051,0.0272904128835093,ATP4B;ATP4A
210,KEGG_2021_Human,Fatty acid elongation,2/27,0.9387993476268046,0.9999957399330064,0,0,0.4321282051282051,0.0272904128835093,ELOVL4;ELOVL2
211,KEGG_2021_Human,Thyroid cancer,3/37,0.942754820808244,0.9999957399330064,0,0,0.4765101936895309,0.0280898133682271,RET;LEF1;HRAS
212,KEGG_2021_Human,Selenocompound metabolism,1/17,0.9442285445832308,0.9999957399330064,0,0,0.337672220442166,0.0193780091626239,INMT
213,KEGG_2021_Human,Inositol phosphate metabolism,7/73,0.9510052025298534,0.9999957399330064,0,0,0.5724208375893769,0.0287559877238316,IPPK;MIOX;PIP5KL1;ITPKA;PLCH1;PLCH2;MTMR7
214,KEGG_2021_Human,Various types of N-glycan biosynthesis,3/39,0.9553442820103112,0.9999957399330064,0,0,0.4499839692209041,0.0205568420930753,MGAT4A;ALG3;B4GALNT4
215,KEGG_2021_Human,FoxO signaling pathway,14/131,0.9590335492917348,0.9999957399330064,0,0,0.6452991452991453,0.0269923606181964,IRS4;G6PC1;GRM1;PRKAG3;KLF2;MAPK12;TGFBR2;CCNB2;CCND2;SKP2;SGK1;HRAS;SGK2;RAG1
216,KEGG_2021_Human,Chemokine signaling pathway,22/192,0.9592671447218426,0.9999957399330064,0,0,0.6974876660341556,0.0290054967676222,VAV3;CCL14;CX3CR1;CXCL6;CCL13;SHC3;ARRB1;CXCL1;ADCY2;PPBP;CXCL13;ADCY8;GNG11;GRK1;GNGT1;GRK7;CCR9;XCL1;HRAS;CCL17;CCL15;CCL26
217,KEGG_2021_Human,Glycosaminoglycan degradation,1/19,0.9602936964203584,0.9999957399330064,0,0,0.3001174837124853,0.0121595922439015,HYAL1
218,KEGG_2021_Human,Platelet activation,13/124,0.9614729319145604,0.9999957399330064,0,0,0.6316187528796084,0.0248155847246762,FGB;FGA;PLA2G4B;FGG;PLA2G4A;ADCY2;F2;ADCY8;MYLK3;MAPK12;GP9;P2RY1;PRKG2
219,KEGG_2021_Human,Pathways of neurodegeneration,61/475,0.962292109616766,0.9999957399330064,0,0,0.7925041073060334,0.0304616596036291,CHRM3;WNT2B;CALML5;LRRK2;CALML3;FZD10;SLC6A3;DNALI1;RYR3;GRM1;TUBB6;UCHL1;PSMD2;NEFL;NEFM;NOS1;HRAS;GPX2;COX8C;DNAI2;WNT5A;COX6B2;DKK4;IL1A;PPIF;HAP1;ND6;DNAH2;DNAH7;BECN2;CHRNA7;DNAH5;DNAH6;NDUFA4L2;CACNA1B;PSEN2;CACNA1D;DNAH9;WNT6;KLC3;TUBA3C;WNT11;DVL3;NDUFV2;DNAI1;GRIA4;SNCA;DNAH12;WNT10B;DNAH10;DNAH17;NOS2;FZD4;WNT3A;FZD7;WNT7B;FZD6;SEPTIN5;MAPK12;GRIN1;CDK5R1
220,KEGG_2021_Human,Circadian rhythm,2/31,0.9651565131552012,0.9999957399330064,0,0,0.3724358974358974,0.0132084394736437,RORC;PRKAG3
221,KEGG_2021_Human,Coronavirus disease,27/232,0.9654933461764196,0.9999957399330064,0,0,0.7095173174671973,0.024915458878574,NRP1;CSF2;RPL10L;TMPRSS2;C8B;C8A;C2;C4B;C3;C4A;C5;C6;C9;MBL2;FGB;FGA;MMP1;FGG;MMP3;F2;RPL3L;IL2;MAPK12;AGTR1;IL6ST;CFB;TLR3
222,KEGG_2021_Human,One carbon pool by folate,1/20,0.9664974233434638,0.9999957399330064,0,0,0.2843049629841987,0.0096881596660036,ALDH1L1
223,KEGG_2021_Human,Neurotrophin signaling pathway,12/119,0.9694407663188724,0.9999957399330064,0,0,0.6047780749466598,0.0187698338580265,NTF4;NGFR;NTRK2;SHC3;CALML5;RPS6KA2;NTF3;PSEN2;CALML3;HRAS;MAPK12;TP73
224,KEGG_2021_Human,Antigen processing and presentation,7/78,0.9697216248267004,0.9999957399330064,0,0,0.5319512581104605,0.0163554975326086,HLA-DMA;HLA-DRB5;CD8B2;KIR2DL1;KIR3DL2;HLA-DPA1;HLA-DQB1
225,KEGG_2021_Human,TNF signaling pathway,11/112,0.9719933588861674,0.9999957399330064,0,0,0.5873346254586886,0.016684007662938,CXCL6;CSF2;JAG1;CREB3L3;CREB3L1;MMP3;CXCL1;VEGFD;SELE;MAPK12;ICAM1
226,KEGG_2021_Human,T cell receptor signaling pathway,10/104,0.9723493407340033,0.9999957399330064,0,0,0.5737570420609309,0.0160882249421405,VAV3;DLG1;CSF2;CD40LG;CD8B2;PAK3;HRAS;IL2;PAK5;MAPK12
227,KEGG_2021_Human,Insulin signaling pathway,14/137,0.9741063240166388,0.9999957399330064,0,0,0.6136014062843331,0.0160977218704406,SHC3;CALML5;IRS4;CALML3;G6PC1;HK2;PRKAG3;GCK;EIF4E1B;HKDC1;EIF4EBP1;PPARGC1A;HRAS;FBP1
228,KEGG_2021_Human,Prostate cancer,9/97,0.9753247689827784,0.9999957399330064,0,0,0.551609087988786,0.0137818245693635,CREB3L3;SRD5A2;CREB3L1;IL1R2;MMP3;LEF1;TMPRSS2;HRAS;FGFR2
229,KEGG_2021_Human,Fanconi anemia pathway,4/54,0.9774270638178464,0.9999957399330064,0,0,0.4317639512508018,0.0098578639564893,FANCI;RAD51;FANCB;FANCE
230,KEGG_2021_Human,Th17 cell differentiation,10/107,0.9788204865761362,0.9999957399330064,0,0,0.5559125964010283,0.0119004305874527,HLA-DRB5;HLA-DMA;RORC;IL1RAP;IL6ST;IL2;MAPK12;HLA-DPA1;TGFBR2;HLA-DQB1
231,KEGG_2021_Human,Cellular senescence,16/156,0.9797317948740908,0.9999957399330064,0,0,0.6158771042222426,0.0126109603941656,CALML5;CALML3;CACNA1D;GATA4;FOXM1;CDC25A;MAPK12;TGFBR2;CCNB2;CCNA1;IL1A;CCND2;CDK6;TRPV4;EIF4EBP1;HRAS
232,KEGG_2021_Human,Mismatch repair,1/23,0.9798759023652692,0.9999957399330064,0,0,0.245492412105677,0.0049907000818167,RFC4
233,KEGG_2021_Human,Insulin resistance,10/108,0.9806484685073246,0.9999957399330064,0,0,0.5502072294213315,0.0107517224896555,CREB3L3;CREB3L1;RPS6KA2;SLC2A1;SLC27A6;PPARGC1A;G6PC1;PPARGC1B;PRKAG3;AGT
234,KEGG_2021_Human,Chagas disease,9/102,0.9845613436349148,0.9999957399330064,0,0,0.5217972498264303,0.0081186817167571,C3;GNA14;NOS2;PPP2R2C;PPP2R2B;KNG1;IL2;MAPK12;TGFBR2
235,KEGG_2021_Human,Bacterial invasion of epithelial cells,6/77,0.9865340017549324,0.9999957399330064,0,0,0.4558118931819414,0.0061796638405073,DNM3;SHC3;CAV3;CLTCL1;WASF1;MET
236,KEGG_2021_Human,Thermogenesis,25/232,0.9867289928282984,0.9999957399330064,0,0,0.6501148844370195,0.0086854398873751,KLB;ND6;NPR1;NDUFA4L2;UCP1;ADCY2;ADCY8;PRKAG3;CREB3L3;CREB3L1;RPS6KA2;DPF1;PRDM16;PRKG2;NDUFV2;PPARGC1A;HRAS;COX8C;ACTL6A;ACSL5;COX6B2;MAPK12;ADCY10;MGLL;COX20
237,KEGG_2021_Human,Thyroid hormone signaling pathway,11/121,0.9872921671737704,0.9999957399330064,0,0,0.5389906782385085,0.0068932962221398,SLCO1C1;NOTCH3;RCAN2;DIO1;SLC2A1;ATP1B3;GATA4;ATP1B1;ESR1;HRAS;MED12L
238,KEGG_2021_Human,Alzheimer disease,43/369,0.9879599115391028,0.9999957399330064,0,0,0.7090741356946024,0.0085891266300707,CHRM3;ND6;WNT2B;CALML5;CHRNA7;BECN2;NDUFA4L2;IRS4;PSEN2;LPL;CALML3;CACNA1D;GPR83;FZD10;RYR3;WNT6;TUBB6;KLC3;TUBA3C;WNT11;PSMD2;DVL3;NOS1;NDUFV2;HRAS;SNCA;WNT10B;COX8C;MME;NOS2;FZD4;WNT3A;FZD7;WNT7B;FZD6;WNT5A;COX6B2;GRIN1;DKK4;IL1A;PPIF;GAPDH;CDK5R1
239,KEGG_2021_Human,Renal cell carcinoma,5/69,0.988306084897464,0.9999957399330064,0,0,0.4214288578761629,0.0049571946154089,SLC2A1;PAK3;HRAS;MET;PAK5
240,KEGG_2021_Human,Natural killer cell mediated cytotoxicity,12/131,0.989027859878536,0.9999957399330064,0,0,0.5434029560377206,0.0059952441841841,VAV3;CSF2;SHC3;RAET1G;RAET1L;KIR2DL1;KIR3DL2;ULBP2;ULBP1;HRAS;ICAM1;ULBP3
241,KEGG_2021_Human,Homologous recombination,2/41,0.9918835523489928,0.9999957399330064,0,0,0.2767751479289941,0.0022555971504858,RAD51;RAD54L
242,KEGG_2021_Human,Progesterone-mediated oocyte maturation,8/100,0.992090879845102,0.9999957399330064,0,0,0.4687386557203094,0.0037220488948949,CCNB2;CCNA1;RPS6KA2;ADCY2;PKMYT1;ADCY8;CDC25A;MAPK12
243,KEGG_2021_Human,Glyoxylate and dicarboxylate metabolism,1/30,0.993874537097564,0.9999957399330064,0,0,0.1861582826017302,0.0011438124318073,HAO1
244,KEGG_2021_Human,Huntington disease,33/306,0.99422189961284,0.9999957399330064,0,0,0.6497888644214316,0.0037654343244324,ND6;DNAH2;DNAH7;BECN2;DNAH5;DNAH6;NDUFA4L2;UCP1;CACNA1B;DNAH9;DNALI1;TUBB6;KLC3;TUBA3C;CREB3L3;CREB3L1;PSMD2;CLTCL1;NDUFV2;PPARGC1A;DNAI1;AP2M1;GRIA4;DNAH12;COX8C;DNAI2;GPX2;DNAH10;DNAH17;COX6B2;GRIN1;PPIF;HAP1
245,KEGG_2021_Human,Glioma,5/75,0.9942544600182586,0.9999957399330064,0,0,0.3851688894999771,0.0022193851604216,SHC3;CDK6;CALML5;CALML3;HRAS
246,KEGG_2021_Human,NF-kappa B signaling pathway,8/104,0.9947985040855312,0.9999957399330064,0,0,0.4491008349389852,0.0023420926451131,EDAR;EDARADD;CCL13;CD40LG;CXCL1;LBP;EDA2R;ICAM1
247,KEGG_2021_Human,Colorectal cancer,6/86,0.995108698337633,0.9999957399330064,0,0,0.4043164313222079,0.0019824860635882,DCC;LEF1;BIRC5;HRAS;EREG;TGFBR2
248,KEGG_2021_Human,Olfactory transduction,50/440,0.995860674073445,0.9999957399330064,0,0,0.6881009615384616,0.0028541854358327,OR9K2;OR4E1;CALML5;OR11H4;OR1G1;ARRB1;CALML3;OR52N2;OR51Q1;OR11H6;PRKG2;CNGA3;OR11H7;OR13D1;CNGA4;OR56B4;OR8D1;OR6C70;OR2D2;OR52I2;OR52I1;OR10AD1;OR6T1;OR56A5;OR2L13;OR9A4;OR7A5;OR2B11;OR10A2;OR52A1;OR4C6;OR10A3;OR6C2;OR10A6;OR56A1;OR10H1;OR52H1;PDE1C;OR52L1;OR5M11;OR2AG1;OR5AN1;OR5AU1;OR10G2;OR10S1;OR2V2;OR6A2;OR13A1;OR7C1;OR2A4
249,KEGG_2021_Human,Legionellosis,3/57,0.9958743649888828,0.9999957399330064,0,0,0.2996686972320188,0.0012388810153518,C3;EEF1A2;CXCL1
250,KEGG_2021_Human,Fc gamma R-mediated phagocytosis,7/97,0.9959057923038872,0.9999957399330064,0,0,0.4191760299625468,0.0017197165734785,VAV3;SCIN;PLA2G4B;SPHK1;PLA2G4A;PLD1;WASF1
251,KEGG_2021_Human,SNARE interactions in vesicular transport,1/33,0.9963207656156456,0.9999957399330064,0,0,0.168675905158603,0.0006217426612189841,VAMP5
252,KEGG_2021_Human,Human T-cell leukemia virus 1 infection,21/219,0.9966177207266236,0.9999957399330064,0,0,0.5704904576236405,0.0019328285792232,NRP1;HLA-DRB5;CSF2;IL1R2;SLC2A1;BUB1B;ADCY2;ADCY8;IL2;ICAM1;TGFBR2;CCNB2;CCNA1;HLA-DMA;DLG1;CCND2;CREB3L3;CREB3L1;HRAS;HLA-DPA1;HLA-DQB1
253,KEGG_2021_Human,Viral carcinogenesis,19/203,0.9967075852938768,0.9999957399330064,0,0,0.5555388193753591,0.0018320818230121,H2BC9;H2BC3;HPN;C3;CCNA1;DLG1;CCND2;SCIN;CDK6;CREB3L3;CREB3L1;H2BC11;H4C2;H4C1;SKP2;IL6ST;H2BW1;HRAS;H2BW2
254,KEGG_2021_Human,Epithelial cell signaling in Helicobacter pylori infection,4/70,0.9969660530412624,0.9999957399330064,0,0,0.3267829027931658,0.0009929490342666931,PTPRZ1;CXCL1;MET;MAPK12
255,KEGG_2021_Human,Lysosome,10/128,0.9972035046600128,0.9999957399330064,0,0,0.4564071282297067,0.001278128381384,NAPSA;ASAH1;HYAL1;NPC2;FUCA1;CLTCL1;CTSH;CTSV;CTSE;AP3B2
256,KEGG_2021_Human,Peroxisome,5/82,0.9975600431780168,0.9999957399330064,0,0,0.3500077080442816,0.0008550472589062946,ACOX2;NOS2;ACSL5;HAO1;BAAT
257,KEGG_2021_Human,Non-small cell lung cancer,4/72,0.9976641901989292,0.9999957399330064,0,0,0.3171339093687507,0.0007416309858078971,RET;CDK6;HRAS;MET
258,KEGG_2021_Human,N-Glycan biosynthesis,2/50,0.9979009865477548,0.9999957399330064,0,0,0.2247596153846154,0.00047226927957739074,MGAT4A;ALG3
259,KEGG_2021_Human,Vibrio cholerae infection,2/50,0.9979009865477548,0.9999957399330064,0,0,0.2247596153846154,0.00047226927957739074,KCNQ1;CFTR
260,KEGG_2021_Human,Lysine degradation,3/63,0.9982125004578564,0.9999957399330064,0,0,0.2696056428342417,0.00048235119294095065,COLGALT2;ALDH2;PRDM16
261,KEGG_2021_Human,Apoptosis,11/142,0.9983241991341906,0.9999957399330064,0,0,0.452020778277523,0.0007581322284950349,TP53AIP1;HRK;NGFR;TUBA3C;BECN2;CTSH;BIRC5;CTSV;BIRC7;HRAS;LMNB2
262,KEGG_2021_Human,Chronic myeloid leukemia,4/76,0.9986232067293206,0.9999957399330064,0,0,0.2994440880906564,0.00041255667326743113,SHC3;CDK6;HRAS;TGFBR2
263,KEGG_2021_Human,Pancreatic cancer,4/76,0.9986232067293206,0.9999957399330064,0,0,0.2994440880906564,0.00041255667326743113,CDK6;RAD51;PLD1;TGFBR2
264,KEGG_2021_Human,Phosphatidylinositol signaling system,6/97,0.9986685497409664,0.9999957399330064,0,0,0.3552102582911312,0.0004732599213968828,IPPK;CALML5;DGKA;ITPKA;CALML3;MTMR7
265,KEGG_2021_Human,Influenza A,14/172,0.9988015007918688,0.9999957399330064,0,0,0.476679210856426,0.0005716422816216462,PRSS1;HLA-DRB5;TMPRSS2;ICAM1;TMPRSS11D;IL1A;HLA-DMA;CDK6;KPNA7;CPSF4L;PRSS2;TLR3;HLA-DPA1;HLA-DQB1
266,KEGG_2021_Human,Amyotrophic lateral sclerosis,37/364,0.9990707700452054,0.9999957399330064,0,0,0.6070480127280568,0.0005643494432563047,ND6;DNAH2;DNAH7;BECN2;DNAH5;DNAH6;NDUFA4L2;DNAH9;DNALI1;TUBB6;KLC3;TUBA3C;ERBB4;PSMD2;NEFL;NEFM;NOS1;NDUFV2;DNAI1;UBQLN3;DNAH12;COX8C;DNAI2;GPX2;DNAH10;DNAH17;NOS2;NRG1;COX6B2;MAPK12;GRIN1;NUP210L;NRG4;MATR3;ANG;HAP1;PFN2
267,KEGG_2021_Human,Mitophagy,3/68,0.999119432522462,0.9999957399330064,0,0,0.248792759020396,0.000219175325740762,CITED2;BECN2;HRAS
268,KEGG_2021_Human,Kaposi sarcoma-associated herpesvirus infection,16/193,0.9991441549519082,0.9999957399330064,0,0,0.4860576031082541,0.0004161681058272859,CSF2;CALML5;BECN2;LEF1;CALML3;CXCL1;GNG11;MAPK12;ICAM1;C3;GNGT1;CDK6;CD200R1L;IL6ST;HRAS;TLR3
269,KEGG_2021_Human,Endometrial cancer,2/58,0.9993820643398248,0.9999957399330064,0,0,0.1925595238095238,0.00011902617551604088,LEF1;HRAS
270,KEGG_2021_Human,C-type lectin receptor signaling pathway,6/104,0.9994346430718628,0.9999957399330064,0,0,0.3297005580152471,0.00018645120539268357,CALML5;CALML3;HRAS;CCL17;IL2;MAPK12
271,KEGG_2021_Human,Tuberculosis,14/180,0.9994499178490804,0.9999957399330064,0,0,0.4534896342125258,0.00024952518937746635,HLA-DRB5;CALML5;NOS2;SPHK1;CALML3;MAPK12;C3;IL1A;HLA-DMA;MRC1;LBP;PLA2R1;HLA-DPA1;HLA-DQB1
272,KEGG_2021_Human,Basal transcription factors,1/45,0.999519610057264,0.9999957399330064,0,0,0.1225860009903585,5.8903231389012594e-05,TAF1L
273,KEGG_2021_Human,Proteasome,1/46,0.999594313298045,0.9999957399330064,0,0,0.1198547474100181,4.863334280778732e-05,PSMD2
274,KEGG_2021_Human,Nucleotide excision repair,1/47,0.999657328667965,0.9999957399330064,0,0,0.1172422439853447,4.018244099578872e-05,RFC4
275,KEGG_2021_Human,mRNA surveillance pathway,5/98,0.9996829118003556,0.9999957399330064,0,0,0.2895153528516874,9.181645973256616e-05,NCBP2L;PPP2R2C;PPP2R2B;MSI1;CPSF4L
276,KEGG_2021_Human,Oocyte meiosis,8/129,0.9996830176412836,0.9999957399330064,0,0,0.3557806122178166,0.00011279405545385697,CCNB2;CALML5;RPS6KA2;CALML3;ADCY2;PKMYT1;ADCY8;MAPK12
277,KEGG_2021_Human,Prion disease,24/273,0.9996974157157078,0.9999957399330064,0,0,0.5173644869989966,0.00015657005203013224,ND6;COX8C;CAV3;NDUFA4L2;CACNA1B;CACNA1D;C8B;COX6B2;C8A;RYR3;MAPK12;GRIN1;IL1A;C5;TUBB6;KLC3;C6;TUBA3C;CREB3L3;CREB3L1;PSMD2;C9;PPIF;NDUFV2
278,KEGG_2021_Human,Spinocerebellar ataxia,9/143,0.9998028293819872,0.9999957399330064,0,0,0.3612582765581025,7.12365407583616e-05,BEAN1;DAB1;PSMD2;MYOD1;BECN2;PPIF;SLC1A6;GRM1;GRIN1
279,KEGG_2021_Human,RNA degradation,3/79,0.9998183191678488,0.9999957399330064,0,0,0.2126440660805588,3.863686077234898e-05,BTG4;PNLDC1;ENO3
280,KEGG_2021_Human,B cell receptor signaling pathway,3/81,0.9998636688009754,0.9999957399330064,0,0,0.2071669913927047,2.8245249733011053e-05,VAV3;LILRA2;HRAS
281,KEGG_2021_Human,RIG-I-like receptor signaling pathway,2/70,0.9999019338307588,0.9999957399330064,0,0,0.1584653092006033,1.5540847859095195e-05,IFNK;MAPK12
282,KEGG_2021_Human,Endocytosis,20/252,0.9999073991207992,0.9999957399330064,0,0,0.4626047711154094,4.283959205028817e-05,SH3GL3;TFRC;CAV3;WIPF3;PARD6G;ARRB1;PLD1;TGFBR2;GRK1;DNM3;ACAP2;PARD6B;GRK7;PIP5KL1;CLTCL1;HRAS;FGFR3;FOLR1;AP2M1;FGFR2
283,KEGG_2021_Human,Oxidative phosphorylation,7/133,0.999941370999027,0.9999957399330064,0,0,0.2987693953986088,1.7517064682539556e-05,ATP4B;ND6;ATP4A;COX8C;NDUFA4L2;COX6B2;NDUFV2
284,KEGG_2021_Human,Diabetic cardiomyopathy,14/203,0.9999450172149176,0.9999957399330064,0,0,0.3977548977548977,2.187027330856186e-05,ND6;COX8C;NDUFA4L2;SLC2A1;COX6B2;AGT;MAPK12;TGFBR2;PDK4;AGTR1;PPIF;REN;NDUFV2;GAPDH
285,KEGG_2021_Human,Parkinson disease,19/249,0.9999456146246952,0.9999957399330064,0,0,0.4432064341660945,2.4104603734566187e-05,ND6;COX8C;CALML5;LRRK2;NDUFA4L2;SEPTIN5;CALML3;COX6B2;RYR3;SLC6A3;UCHL1;TUBB6;KLC3;TUBA3C;PSMD2;PPIF;DRD2;NDUFV2;SNCA
286,KEGG_2021_Human,Necroptosis,9/159,0.9999668899204944,0.9999957399330064,0,0,0.3224156761965949,1.0675385405081147e-05,H2AC11;H2AC12;IL1A;H2AC8;PLA2G4B;ALOX15;PLA2G4A;MACROH2A2;TLR3
287,KEGG_2021_Human,NOD-like receptor signaling pathway,11/181,0.9999723394829704,0.9999957399330064,0,0,0.3475107304252463,9.612459420355592e-06,CASR;NLRP12;NLRP7;DEFA5;CARD18;TXNIP;PYDC1;PYDC2;CXCL1;DEFB4A;MAPK12
288,KEGG_2021_Human,Lipid and atherosclerosis,14/215,0.9999816810025994,0.9999957399330064,0,0,0.3737394110528438,6.846594011127351e-06,VAV3;CALML5;MMP1;MMP3;APOA1;CALML3;CXCL1;SELE;MAPK12;ICAM1;CD40LG;LBP;APOB;HRAS
289,KEGG_2021_Human,Yersinia infection,6/137,0.9999882622728212,0.9999957399330064,0,0,0.2461611578751384,2.889389470615152e-06,VAV3;RPS6KA2;WIPF3;CD8B2;IL2;MAPK12
290,KEGG_2021_Human,Epstein-Barr virus infection,12/202,0.9999889441769796,0.9999957399330064,0,0,0.3388999830766627,3.7468389467483874e-06,CCNA1;HLA-DRB5;HLA-DMA;CCND2;CDK6;PSMD2;ENTPD8;SKP2;MAPK12;ICAM1;HLA-DPA1;HLA-DQB1
291,KEGG_2021_Human,Osteoclast differentiation,5/127,0.9999899456821232,0.9999957399330064,0,0,0.220314825625733,2.2151264256035578e-06,IL1A;CALCR;LILRA2;MAPK12;TGFBR2
292,KEGG_2021_Human,Hepatitis B,8/162,0.9999903502471682,0.9999957399330064,0,0,0.2789914003786836,2.692211045457786e-06,CCNA1;CREB3L3;CREB3L1;BIRC5;HRAS;TLR3;MAPK12;TGFBR2
293,KEGG_2021_Human,Ubiquitin mediated proteolysis,6/140,0.9999907757266844,0.9999957399330064,0,0,0.2406069779472343,2.219434762610064e-06,AIRE;UBE2S;KLHL13;BIRC7;SKP2;RHOBTB2
294,KEGG_2021_Human,PD-L1 expression and PD-1 checkpoint pathway in cancer,2/89,0.9999917730360222,0.9999957399330064,0,0,0.1237179487179487,1.0178272943350597e-06,HRAS;MAPK12
295,KEGG_2021_Human,Toll-like receptor signaling pathway,3/104,0.9999920046131612,0.9999957399330064,0,0,0.159771315380977,1.277438579050626e-06,LBP;TLR3;MAPK12
296,KEGG_2021_Human,Non-alcoholic fatty liver disease,7/155,0.9999925828119366,0.9999957399330064,0,0,0.2540236866079562,1.8841484436816737e-06,IL1A;COX8C;NDUFA4L2;COX6B2;NDUFV2;PRKAG3;MAPK12
297,KEGG_2021_Human,Human cytomegalovirus infection,13/225,0.9999937730132642,0.9999957399330064,0,0,0.3287139588656184,2.046903834757378e-06,CALML5;PTGER2;CALML3;ADCY2;ADCY8;GNG11;MAPK12;GNGT1;CDK6;CREB3L3;CREB3L1;EIF4EBP1;HRAS
298,KEGG_2021_Human,Ribosome biogenesis in eukaryotes,3/108,0.9999938866715912,0.9999957399330064,0,0,0.1536481472999587,9.393044550112142e-07,FBL;LSG1;FBLL1
299,KEGG_2021_Human,Herpes simplex virus 1 infection,21/498,0.9999939286384164,0.9999957399330064,0,0,0.2328463733549129,1.4136988176086088e-06,ZNF540;HLA-DRB5;ZNF99;C3;ZNF90;C5;HLA-DMA;ZNF729;ZNF727;ZNF429;ZNF208;EIF4EBP1;ZNF578;ZNF556;ZNF214;ZNF676;TLR3;HLA-DPA1;ZNF486;HLA-DQB1;NECTIN1
300,KEGG_2021_Human,Autophagy,5/137,0.999994400940676,0.9999957399330064,0,0,0.2035027853122174,1.1394273574173406e-06,DEPTOR;DAPK1;BECN2;IRS4;HRAS
301,KEGG_2021_Human,MicroRNAs in cancer,20/310,0.999994460317668,0.9999957399330064,0,0,0.3687943262411347,2.043009072064692e-06,TRIM71;NOTCH3;ABCC1;TNXB;WNT3A;CDCA5;KIF23;EFNA5;HOXD10;SERPINB5;CDC25A;FOXP1;CCND2;CDK6;CYP24A1;FSCN1;HRAS;FGFR3;MET;TP63
302,KEGG_2021_Human,Human immunodeficiency virus 1 infection,11/212,0.9999946999342578,0.9999957399330064,0,0,0.2933692194763885,1.554880270442993e-06,GNGT1;CCNB2;CALML5;CALML3;PAK3;GNG11;HRAS;APOBEC3A;PAK5;MAPK12;APOBEC3B
303,KEGG_2021_Human,Measles,5/139,0.9999947446912916,0.9999957399330064,0,0,0.2004414884193086,1.0533846675537951e-06,IL1A;CCND2;CDK6;IL2;TP73
304,KEGG_2021_Human,Shigellosis,13/246,0.9999949189462904,0.9999957399330064,0,0,0.2987105137100236,1.5177680197361468e-06,H3C8;CSF2;BECN2;HK2;MAPK12;C3;H3C15;MYL7;HKDC1;H3C1;WASF1;H3C7;PFN2
305,KEGG_2021_Human,Salmonella infection,12/249,0.9999949911671244,0.9999957399330064,0,0,0.2709267776466278,1.3570303493520175e-06,TUBB6;KLC3;MYL7;TUBA3C;FHOD1;LEF1;PAK3;HRAS;GAPDH;DYNC1I1;MAPK12;PFN2
306,KEGG_2021_Human,RNA transport,7/186,0.9999953923049436,0.9999957399330064,0,0,0.2096415793107777,9.659666940692655e-07,FXR1;NUP210L;NCBP2L;EIF4E1B;EEF1A2;EIF4EBP1;THOC3
307,KEGG_2021_Human,Protein processing in endoplasmic reticulum,4/171,0.9999955556883036,0.9999957399330064,0,0,0.1283718643533971,5.705258460519911e-07,LMAN1L;HSPA4L;CRYAB;UBQLN3
308,KEGG_2021_Human,Ribosome,2/158,0.999995667896885,0.9999957399330064,0,0,0.0687130177514793,2.976725230175772e-07,RPL10L;RPL3L
309,KEGG_2021_Human,Spliceosome,2/150,0.9999957399330064,0.9999957399330064,0,0,0.0724618849618849,3.086931419481653e-07,NCBP2L;THOC3
